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1 Introduction
Radiotherapy (RT) is an established treatment option for cancer patients, along
with chemotherapy and surgery. The aim of RT is to apply a sufficiently high ra-
diation dose to the tumor to kill the cancerogenous cells, while at the same time
minimizing the dose burden to the surrounding healthy tissues to preserve their
function. Therefore RT offers different forms of treatments such as brachytherapy,
where tiny radioactive sources are brought close to the tumor, and external beam RT
(teletherapy), where patients are treated with high-energy X-rays (photons), elec-
trons or protons. All these treatments need to be planned on a patient individual
basis to ensure that the tumor is irradiated with the prescribed dose, while surround-
ing healthy tissues are protected from the dose burden. The focus of this work is on
external beam RT with high-energy photons, which is for simplicity denoted as RT
hereafter.
Patient individual planning in RT is needed due to different anatomies and because
modern RT treatment machines offer different options to apply radiation dose. Dur-
ing the planning process the treatment angles, field shapes and field intensities need
to be defined. To ensure that a sufficiently high radiation dose is delivered to the
tumor and that other structures are spared from the dose burden as much as possi-
ble, all these opportunities need to be taken into account when generating patient
individual treatment plans. Hence, different treatment options need to be simulated.
However time constraints and the experience of the planner may impact the quality
of the plan. Finding a balance between the dose administered to the tumor and the
dose burden to surrounding tissues is challenging and therefore attention to auto-
matic planning has increased in recent years [1–7].
In this introduction, the current status of RT treatment planning is briefly described,
followed by a description of constrained optimization and several so far introduced
automatic planning approaches. Then the idea of using particle swarm optimiza-
tion (PSO) as an automatic RT treatment planning approach is introduced. In the
main part of this thesis the implementation of such an approach is described in
detail, the quality of the implementation is analyzed and the applicability is shown
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for post-operative prostate cancer treatments.
1.1 Radiotherapy treatment planning - an
optimization problem
Since the late 1980s, the basis of 3D treatment planning has always been a CT scan,
which represents the patient individual anatomy as a 3D density distribution [8].
The physician delineates the region of interest (ROI), i.e. organ at risk (OAR) and
tumor on this planning CT scan, see figure 1. In addition to previous diagnostic
scans, a planning CT needs to be acquired by standardized protocols. First of all,
the patient is immobilized on a flat table top, which is identical to the treatment
table at the RT treatment unit (LINAC). Several positioning aids, as can be seen in
figure 2, are used to support and enable the patient to hold the treatment position
for several minutes. This is important as the patient needs to take exactly the same
position for every following treatment fraction. Standardized scanning protocols are
also needed to ensure the correct conversion from CT Hounsfield Units to electron
densities. The different electron densities of bony structures and soft tissues are
later needed to accurately calculate the deposited dose during the planning process.
To facilitate the delineation of the structures, other imaging modalities are also
used. These includes magnetic resonance tomography (MRT), which is used due to
the improved soft tissue contrast compared to CT, and positron emission tomogra-
phy (PET), which provides additional metabolic information. All additional image
information needs to be fused to the CT scan, to ensure that the spatial informa-
tion matches. Additional planning scans should be preferably acquired in treatment
position to facilitate the fusing of different image series.
Figure 1: Planning CT scan of a prostate cancer patient in supine position with contoured
structures: tumor bed, rectum, bladder and femoral heads.
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Figure 2: Medical LINAC with positioning aids on the treatment table which are typically
used to comfort a prostate patient in supine position, 1 pillow to rest the head, supportive aid
for the knees and 3 fixation to rest the feet.
After delineation, the beam field shapes and intensities need to be defined. In
3D-CRT, the treatment fields are shaped to the outline of the tumor projection.
Apertures, wedges and compensators are used to shape the fields and intensity pro-
files. However, 3D-CRT is unable to account for complex arrangements of target
and OAR structures, such as a tumor bending around the spine. The high dose
region cannot be conformed precisely to the target outline, see figure 3 a), hence
surrounding healthy tissue cannot be properly shielded from dose burden.
In 1988, Brahme pioneered the idea of inverse planning [9], which derives the initial
beam profile intensities from the desired dose distribution. This was the theoretical
beginning of modern intensity modulated radiotherapy (IMRT) treatments. Never-
theless, in the following years several optimization approaches and technical devel-
opments were needed to bring IMRT into clinical practice.
The modulation of a radiation field is reached by the superposition of different seg-
ments which are formed by the MLC as is sketched in figure 4. By combining
radiation fields from several beam directions, complex and highly conformal dose
distributions can be achieved, c.f. figure 3 b). In step and shoot IMRT the first
segment is shaped by the multileaf collimator (MLC), then appropriate radiation
is applied and after radiation is off, the leafs of the MLC move to form the next
segment. During gantry rotation to the next beam direction, the radiation is also
turned off. Depending on the total number of segments, treatment time is up to sev-
eral minutes. The next technical invention is IMRT delivery with dynamic multileaf
collimators (dMLC), where the MLC leafs move with varying velocity from one field
edge to the opposite while radiation is on. Thereby the intensity is modulated by
sliding the leafs through the radiation field. Only during gantry rotation the beam is
3
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turned off. The next step is to leave the beam also on during gantry rotation, which
is denoted as volumetric modulated arc therapy (VMAT). Hence VMAT treatments
are not restricted to defined beam angles, but make use of the entire 360° of a circle.
a) 3D-CRT b) VMAT
Figure 3: Comparison of 3D-dose distributions for 3D-conformal radiotherapy (3D-CRT)
and volumetric modulated arc therapy (VMAT) prostate treatments. In 3D-CRT, fixed beam
angles are used and the field is shaped to the projection of the tumor outline, but the intensity
in the field is not modulated. In this example, 4 beam angles from 0°, 90°, 180° and 270° result
in a rectangular shape the high-dose region (red) around the round prostate (blue line). In
contrast, a VMAT treatment uses all beam angles of the 360° circle and modulated intensities
and therefore offers better conformance to the shape of the tumor. Nevertheless, the entire
surrounding tissue is exposed to low doses (blue), whereas in 3D-CRT less healthy tissue is
exposed.
1 2 3 4 5 Σ
+ + + + =
Figure 4: IMRT principle: Intensity modulation reached by the superposition of 5 differently
shaped, non-modulated segments.
Considering this technical improvement and also other inventions, such as flattening
filter free (FFF) beams, which allow for higher dose rates, the modulation of the
dose rate (MU per min), and the integration of imaging modalities such as MRT
and PET modern external beam radiotherapy with a state-of the art high-precision
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LINAC is able to cover an enormous amount of degrees of freedom. Consequently,
highly individualized treatments can be offered to the patients. However, the high
amount of steering parameters make treatment planning more complex and chal-
lenging. To make use of these opportunities, treatment planning has shifted from
forward planning to inverse planning, which means that the desired radiation dose
for PTV and maximum tolerated doses for healthy tissues are defined in the form of
objectives and constraints and the treatment planning system (TPS) optimizes the
needed machine parameters to apply this dose.
In figure 5, some technical steering parameters in addition to the dose objectives
and constraints are depicted as a spider net. The figure illustrates that as the net
becomes more branched, it also becomes more complicated to predict what will hap-
pen if one bifurcation is shifted. Therefore modern RT treatment planning needs to
be seen as an optimization problem. We hypothesize that the solution of this opti-
mization problem can be found by applying inverse planning algorithms, producing
the appropriate controls for the LINAC. While the solution of the optimization
problem may be considered as trivial, the formulation is definitely not. Currently
this is typically a time consuming trial and error process, where the planner tries out
different combinations of objectives and constraints, i.e. formulations of the patient
individual treatment planning problem, until a satisfying treatment plan is founded.
Nevertheless, this process is restricted by the time available until a treatment plan
needs to be ready and by the planner’s experience.
Figure 5: Modern RT treatment planning is an optimization problem with an enormous
amount of degrees of freedom. The technical options influence the dose to the PTV and
OARs, making the definition of the objectives and constraints crucial for the inverse planning.
This system is like a spider web, it will collapse if one cord is pulled too much.
(planning target volume (PTV), organ at risk (OAR), image guided radiotherapy (IGRT),
monitor unit (MU), multileaf collimator (MLC), flattening filter free (FFF)).
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1.2 Plan quality measures in radiotherapy (RT)
In clinical practice the planner and the physician judge the quality of a treatment
plan by visual inspection of the 3D-dose distribution. The 3D-dose distribution is
normally inspected in axial, coronal and sagittal views. Figure 7 shows one example
for each of the three different view types and a scheme of them. The dose distribution
is represented as isodoselines, to all voxels inside the isodoseline a dose as high or
higher than the isodose is applied and to voxels outside the isodoseline a lower dose
is applied.
3D-dose distributions give detailed information about the applied dose, but it is
difficult to compare two dose distributions and to identify key dose information.
Therefore dose volume histograms (DVH) were established as standard tools to
evaluate dose distributions in RT treatments. A DVH is a histogram where the
number of volume elements is plotted as a function of the applied dose. This is also
known as differential DVH. A cumulative DVH is generated by integration from the
right to the left and is therefore a histogram denominating the number of volume
elements which receive at least the defined dose. The volume elements are frequently
represented as percentage volume fractions. A differential and a cumulative DVH
are presented in figure 6. In RT, cumulative DVHs are generally used and normally






























Figure 6: Figure a) presents a differential dose-volume-histogram (DVH), where the number
of volume elements receiving a defined dose is plotted. By integration from the left to the
right a cumulative DVH is calculated (figure b). Cumulative DVHs therefore represent the
volume which receives at least the defined dose.
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DVHs are representations of 3D-dose distributions, relatively simple to comprehend
and useful to compare different treatment plans. It is easy to assess minimum and
maximum doses and therefore the homogeneity of the dose applied to the target and
also overdosing (hot spots) received by OARs are easily observed. Therefore DVHs
are useful for documentation of important dose parameters including maximum dose
Dmax, minimum dose Dmin, near maximum dose D2%, near minimum dose D98%
and median dose Dmedian or D50%. Nevertheless, a DVH does not provide spatial
information. However, a 3D-dose distribution does. For evaluation, a DVH should




c) coronal plan d) sagittal plan
Figure 7: Plan quality is inspected in 3D-dose distributions overlaid on the planning CT.
The dose distribution is represented as isodoselines. The dose distribution is depicted in axial,
coronal and sagittal views. A sketch of the three view types is provided in a). For each view
type a single dose plan is presented in sub-figures b)-d).
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1.3 Constrained Optimization in radiotherapy (RT)
treatment planning
In modern RT treatment planning optimization is considered essential and the po-
tential of intensity modulation to tailor conformal dose distributions for arbitrary
volumes while placing the steepest dose gradient precisely between the target and
the most sensitive OAR is recognized [11]. The optimization depends on the precise
description of the desired dose distribution, therefore dose objectives and constraints
are used. Dose objectives are requirements which should to be met to the extend
possible, whereas constraints are mandatory requirements that must be met. In
RT planning, a distinction is made between physical and biological constraints and
objectives. Therefore described briefly in the following two sections.
1.3.1 Physical objectives and constraints
Physical constraints are constraints which are defined in physical quantities. For RT,
dose and volume are particularly important quantities. Another physical constraint
which is assumed for every treatment planning optimization is the non-negativity
of beam intensities. A well known and often used physical objective is the mean-
square deviation between calculated dose distribution and ideal prescription, which
is part of a minimization. This objective is also known as least-square optimiza-
tion, in which it may be hard to balance target and OAR prescriptions adequately.
Therefore, least-square optimization is often combined with individual constraints
for OARs.
A common constraint is the maximum dose constraint, limiting the maximum dose
to an OAR. By definition maximum dose constraints are very strict, which can be
difficult to handle for optimization algorithms. Therefore maximum constraints are
often combined with penalty factors, which measure the importance of holding a
maximum dose constraint. Normally, the penalty factor increases the further the
constraint is exceeded, typically with the squared excess beyond the tolerance dose.
A graphical representation of maximum constraint with low and high penalty factor
is depicted in figure 8. The grey area in the DVH visualizes the area where the
penalty is active. With small penalty factors a slight violation of the maximum
dose Dmax is possible, whereas high penalty factors prevent the exceeding of Dmax.
Minimal dose constraints are also used for target structures.
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Figure 8: Application of maximal dose constraints in critical structures. (A) The use of a
small penalty factor allows for some excess dose beyond the threshold Dmax. (B) A large
penalty factor prevents the delivery of any dose beyond the threshold. Reprinted from [11]
with permission from Elsevier.
With respect to OARs, often not just the maximum dose needs to be controlled, but
also distinct dose points referring to a dose given to a certain volume of an OAR.
Therefore the so called DVH-constraint is used to limit the volume Vmax of an OAR
receiving a dose Dmax. The rationale for this approach is, that a structure’s tissue
may keep its function if a sufficient amount of volume is not exposed to more than
the appropriate threshold dose. A graphical representation is given in figure 9. The
grey area visualizes the forbidden area of the DVH.
Figure 9: Structures with a large volume effect are more appropriately spared through the
application of dose-volume-histogram (DVH) constraints. They prevent the DVH from going
above the point pDmax, Vmaxq. Reprinted from [11] with permission from Elsevier.
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1.3.2 Biological objectives and constraints
Describing dose distributions by physical dose objectives and constraints is straight-
forward, as physical quantities are well defined and measurable. Nevertheless, the
same physical constraint may have different meanings to different ROIs, in terms
of biological dose-effect. Therefore constraints and objectives describing dose-effects
for structures were proposed for the field of RT planning. To describe dose-effects
F to targets or G to OARs mathematically the dose-effect for a volume is defined









Functions fpDq and gpDq are local effect densities and Di is the dose to the ith
volume element. For normal tissues gpDq denominates the damage in a voxel in-
duced by a dose D, therefore gpDq is by definition a continuous and monotonically
increasing function. The upper limit is the total damage of the structure. Local ef-
fect densities for normal tissues can be mathematically defined as sigmoid function
[12]:
gpDq  1{p1   pD0{Dqkq (3)
D0 is the maximum accepted dose and hence the inflection point of the sigmoid,
parameter k describes the characteristic slope of the dose-effect. With increasing k
the sigmoid approaches a step function. A biological description for the tolerance of
a structure with respect to radiation dose is given by the volume-effect. The higher
the volume-effect of a tissue is, the more gpDq differs from a step function and vice
versa.
Structures with high volume-effects, and corresponding small k, will tolerate over-
dosage in a small sub-volume if an adequate portion is spared from dose. The
remaining cells are able to maintain the function of the entire structure. Sometimes
this is illustrated as a rope [12], where single-strands will burst, but the rope will
not. Structures with high volume-effects are denominated as parallel structures. An
ideal dose-constraint for a parallel structure should control doses around the inflec-
tion point D0, see figure 10. Dose values beneath D0 are uncritical, whereas doses
above this limit destroy the cell, but even further escalation will not cause more
harm. Therefore small sub-volumes will be exposed to doses higher than D0 if this
will allow for substantial sparing for doses lower than D0. The parallel constraint
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is conceptually equal to the DVH constraint, the difference is that it offers control
over a region of the DVH and not only one single point. Organs which are typically
seen as parallel organs are lung, liver, kidney and parotid glands.
Figure 10: A typical DVH for a parallel organ, e.g. lung. The length of the arrows signifies
the control over each dose bin exacted by the parallel Reconstruction Unit (or parallel gEUD)
model. Arrow lengths correspond to realistic values for lung with the longest arrow being at
20Gy. The cost of increasing the high dose bins is relatively low, reflecting the fact that it
does not cause any more harm to increase the dose above a certain threshold which is assumed
to obliterate organ function. Since the volume receiving at most this threshold dose is most
relevant for conserving tissue function, the cost function assigns the greatest weight to the
dose bins at this threshold. Reprinted from [12] with permission from Elsevier.
In contrast, for structures with a small volume-effect the function of a destroyed
cell cannot be assumed by the remaining ones, hence the destruction of a single cell
causes loss of functionality for the entire structure. Therefore these structures are
sensitive to overdosage and a planning-constraint needs to control the maximum
dose to the structure. This could be visualized by a chain which collapses if one
chain link breaks [12]. An appropriate constraint needs to control the high dose
region, as shown in figure 11. Rectum, eyes, brain stem and spinal cord are typical
examples for serial behaving organs.
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Figure 11: A typical DVH for a serial organ, e.g. rectum. The salient feature of a cost
function for dose optimisation in the lo- cal dose-effect measure formalism is the way in which
it affects the shape of the DVH. The length of the arrow signifies the con- trol over each dose
bin exacted by the serial Reconstruction Unit (or gEUD) model. The last arrow is truncated.
Arrow lengths correspond to realistic values for rectum. The cost of increasing the high dose
bins outweighs the cost for the lower dose bins by far, so that the volume receiving these high
doses is controlled most tightly while the volume receiving low or intermediate doses is not
controlled and hence depends on the circumstances of patient geometry. Reprinted from [12]
with permission of Elsevier.
Dose distributions, especially for OARs, are normally not homogeneous. An in-
homogeneous dose distribution has an impact on the efficiency of RT, hence it is
important to describe this effect mathematically. For comparison of different RT
treatment plans, a metric to compare plan efficiency is also beneficial. Therefore
the concept of equivalent uniform dose (EUD) was introduced by Niemierko in 1997
[13], where two dose distributions are considered as equivalent if they cause the same
biological effect. For tumors biological effect is related to the number of surviving
clonogenic cells, while for an OAR the biological effect is related to the function of
the structure.
If a tissue volume element receives a homogeneous dose, then the biological effect
provoked by this dose is precisely defined by this value. Hence, if two dose dis-
tributions are considered to have the same biological effect and one of them is a
homogeneous distribution, the inhomogeneous dose can be precisely defined with
the dose value for the homogeneous dose distribution which would cause the same
effect. This dose is denoted as equivalent uniform dose (EUD), because the biologi-
cal effect of the inhomogeneous dose equals the effect of homogeneously distributed
dose of a certain value. A prerequisite for considering two doses as equivalent is that
the same fractional scheme was used, i.e. using the same number of fractions, dose
per fraction and total time of treatment.
To apply the concept for OARs, Niemierko also augmented it as generalized equiva-
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where tvi, Diu are dose-volume bins from the DVH and a is a tissue specific param-
eter. For targets, 0   a   1, which tears the gEUD towards the minimum dose,
whereas for OARs a ¡ 1 with increasing a pushing the gEUD towards the maxi-
mum dose. For a  1 the gEUD equals the mean dose Dmean. For the same dose
distribution in one OAR different EUD values are possible, depending on the clini-
cal endpoint which is evaluated [15]. Nevertheless, EUD values depend on clinical
models and thereby the clinical relevance is crucially related to the quality of clinical
data [15]. EUD is used to describe serial constraints [12].
The cell survival probability in the target volume can be used as biological objec-








The objective function assumes a homogeneous cell density inside the target and α




In modern radiotherapy treatments, dose-effects to tissues are described as a math-
ematical function (sections 1.3.1 and 1.3.2). To describe physical dose distributions,
these dose-effects are combined as a vector containing the total effect in n target
volumes and additionally in m healthy tissues in the (n+m) dimensional space [12]:
pF1, ...Fn, G1, ...Gmq P r0,8rn m (6)
In the simplest case of only one target and one normal tissue effect, this would
be a two dimensional vector. All mathematical combinations of these two effects
then span a plane, see figure 12. But not all theoretically possible combinations
are physically realizable, which why a boundary is introduced, separating physi-
cally realizable plans from un-realizable plans [12]. This boundary is also called
the pareto-front or in higher dimensions pareto-surface. This frontier is defined by
combinations where it is impossible to reduce one dose-effect without deteriorating
the other one. An optimization aims at finding vectors which point at this pareto-
surface, and the plans are called pareto-optimal. Plans above the pareto-front are not
pareto-optimal and therefore clinically unfavorable whereas plans below this front
are physically in-feasible. The pareto-optimal combinations are then calculated by
defining a multi-parametric costfunction for the optimization problem. This could








By solving this Lagrange function, a pareto-optimal dose-distribution is defined. By
altering the Lagrangian multipliers λ, the weighting of the dose-effects is changed
and the pareto-front can thereby be navigated. As the dose-effect in the target vol-
ume and the normal tissue interact, it is possible to describe the dose-effect to the
target volume as function of the dose effect of the normal tissue [12]. Therefore the







λjpGj  Cjq (8)
Each normal tissue effect needs to fulfill the constraint Gj ¤Cj. By setting these
constraints for the normal tissue dose-effects, we choose clinically favorable plans
out of the infinite number of pareto-optimal plans. Therefore this optimization
technique is named constrained optimization. It is important to understand the dif-
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ference between a pareto-optimal and a clinical optimal plan. As the aforementioned
pareto-optimality means that no dose-effect can be further minimized without dete-
riorating another dose-effect, a clinically optimal plan is preferably a pareto-optimal
plan. As a plan with very strict OAR constraints will cause a poor target coverage,
this is obviously not a clinically optimal plan, but it can be a pareto-optimal plan.
Furthermore, it should be mentioned that one has to choose appropriate constraints
to turn a pareto-optimal plan into a clinically optimal one. The constraints have to
reflect the parameters that are evaluated to ensure plan quality, i.e. if the rectum
high dose sparing is to be evaluated, definition of a constraint that monitors high
doses to the rectum is needed.
Figure 12: Schematic drawing of a pareto-front (F1 target dose-effect, G1 OAR dose effect,
blue line pareto-front, dotted area physically feasible plan, white physically i n-feasible area,
red rhombus non pareto-optimal plan, red points pareto-optimal plans). By choosing an
appropriate constraint value C the clinically optimal plan is chosen out of the infinite amount
of pareto-optimal plans. C1 would represent a plan with poor target dose, but strict OAR
sparing, whereas C2 represents a plan with good target dose but inferior OAR dose sparing.
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1.4 Automatic Treatment planning - current status
As aforementioned, manual planning is time consuming and highly related to the
planner’s experience and allocated time. To overcome these problems, automatic
treatment planning has gained attention in recent years [1–7]. Several concepts
have been introduced and some of them are already available in commercial treat-
ment planning systems.
Pinnacle AutoPlanning
In 2003 Cotrutz and Xing introduced a regionally variable penalty scheme to shape
IMRT dose distributions [17]. The idea is that a dose distribution could be consid-
ered nearly acceptable, but a few subvolumes or regions of the DVH need improve-
ment. As planning objectives normally concern the whole structure it is impossible
to control these subvolumes. Therefore, in addition to structure importance factors,
Cotrutz and Xing introduced voxel-based importance factors, which are applied to
these subvolumes only. Previously these subvolumes were defined manually by the
planners by drawing the outlines with a computer mouse or identifying sub-optimal
regions of the DVH. Xhaferllari et al. later further developed this approach to
a first automatic planning concept by defining these subvolumes automatically by
converting isodoselines into structure outlines for these subvolumes [18]. To auto-
matically identify regions which need improvement they use a reference plan, which
is automatically chosen from a library of previously treated patients, containing
dose distributions and DVH information. This approach is available in the TPS
Pinnacle3 (Philips Medical Systems, Fitchburg, Wisconsin, USA) as AutoPlanning
module and has proven clinical applicability for different tumor sites such as head
and neck cancer [19–22], Hodgkin lymphoma [23], prostate [24], brain [24] and hep-
atocellular carcinoma [25].
Erasmus iCylce
A second approach is the so called iCylce, which was introduced by Breedveld
et al. [26, 27] at the Erasmus University Rotterdam. iCycle uses the 2-phase ε-
constraint (2pεc) optimization method. Therefore a so called wishlist needs to be
designed containing prioritized constraints and objectives. This wishlist is a treat-
ment specific template which is used as a class solution and represents a starting
point for individual patient planning, but it needs further refinement for individual
patients. In the beginning of the optimization, objectives are minimized to reach
pre-defined goals, minimizing objectives one after the other, starting with the high-
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est priority. Before moving on, the reached objective value is set as an additional
constraint for the following minimization of lower priorities. It may be the case that
objectives could be further minimized than the specified goal. This is done in a
second phase, where all objectives are minimized to their full extent, again moving
from the highest to lowest priority levels. This is not done in the first phase as
minimizing a higher prioritized objective further than the goal could jeopardize a
lower prioritized objective from reaching the goal [27]. iCycle is used as an IMRT
optimizer and also selects optimal beam angles [27]. The approach has been success-
fully tested for head and neck cancer [28, 29] and for prostate patients with metal
hip prostheses [30]. Voet et al. showed that by linking iCycle to the TPS Monaco
(Elekta, Stockholm, Sweden) it is possible to generate VMAT plans automatically
[31]. This showed clinical applicability for several tumor sites: different prostate
treatments [1, 32, 33], gastric cancer [4] and cervical cancer [34, 35]. Coupled with
the TPS Multiplan® (Accuray, Sunnyvale, USA) iCycle can also calculate treatment
plans for non-co-planar treatments with the CyberKnife (Accuray, Sunnyvale, USA)
[7]. Nevertheless, there is as risk that the strict execution of the wislist results in an
unfavorable position, e.g. a slight relaxation of a higher prioritized constraint could
allow for a much better solution for a less prioritized constraint and this better spar-
ing of the lower prioritized organ may outweigh the sparing in the higher prioritized
organ. Another problem with the 2pεc optimization in iCycle is that the number of
optimization problems and therefore the computation time is related to the number
of constraints, because iCylce solves a consecutive number of optimization’s which
scale with the number of constraints. To overcome these problems the lexicographic
reference point method (LRPM) was introduced [36, 37].
In contrast to the 2pεc method, the LRPM needs only one single optimization to
reach a Pareto-optimal plan. Reference points and global trade-offs serve as in-
put parameters and are treatment intent and site specific. Reference points define
goal values for the objectives, whose achievements are considered equally important.
The lexicographic ordering introduces multiple reference points and the deflection of
these points is then the so called reference path, which steers the optimization. The
first priority for the LRPM is to reach the first reference point and then go on to the
next until it is impossible to further improve any objective. As this is also the defini-
tion of a pareto-optimal plan, this point is the intersection of the pareto-surface and
the reference path. But this plan does not necessarily reflect a clinically favorable
plan. Therefore a bend to the indifferent curve is introduced. The indifferent curve
is a set of points where the optimized overall function takes a certain constant value.
By definition these indifferent curves comply to the strict lexicographic ordering.
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But by tilting these indifferent curves, one might allow for a small deterioration
in a higher prioritized objective which is rewarded by a meaningful gain for a less
prioritized objective. This is called a global trade-off and converts the strictly lexi-
cographic ordering to a fuzzy ordering. Van Haveren et al. introduced this method
and showed the applicability and superiority of the LRPM in terms of computation
time while maintaining plan quality for prostate [36] and head and neck cancer cases
[37].
RapidPlan
Another approach, which is based on a model trained on previously treated plans,
was introduced by Yuan et al. in 2012. The idea of this approach is to predict the
best achievable OAR sparing based on the knowledge and experience of previously
treated plans [38]. A training dataset containing these previously treated plans is
used to build a support vector regression model, which is then used to map extracted
anatomical features of the PTV and OARs to dose-volume features and hence pre-
dicts DVHs. To train a good model, high-quality clinical plans are needed to extract
anatomical and volumetric features. Volumetric features are OAR and target vol-
umes, overlapping volumes between OAR and PTV, and the OAR volume which
is outside the primary treatment fields. The spatial information is provided by a
distance to target histogram (DTH), which evaluates the fraction of OAR volume
within a maximum distance to the PTV surface. By definition, negative distances
are assigned to OAR voxels intersecting the PTV. The models need to be trained
site specific and the quality of the training dataset is crucial for the quality of the
model. The training dataset needs to reflect the full anatomical variation and also
clinical trade-offs. As the approach is able to predict the DVHs, it can be used
for automatic planning by extracting OAR constraints from the prediction. There-
fore plan quality was shown to be improved in terms of variation among patients,
planners’ experience, time allocated to the task and complexity [38]. Appenzoller
et al. introduced a very similar approach, which also uses a model trained on pre-
vious plans to predict achievable OAR DVHs from the individual patient anatomy
[39]. They use information from so called sub-DVHs, which means that the OAR is
divided in sub-structures that are equally distant from the PTV. Using this infor-
mation, the spatial and volumetric features are related to dose, and the model can
be trained on this data.
In this manner, the software RapidPlanTM for the TPS EclipseTM (Varian Medical
Systems, Palo Alto, CA, USA) was developed as a knowledge based planning tool
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and has since then been tested for several treatment sites ranging over different com-
plexities and covering IMRT and VMAT: head and neck [40–42], prostate [43, 44],
breast [45, 46] and gastrointestinal treatments [47, 48].
Raystation
In treatment planning the challenge is to find a reasonable compromise between
target dose and normal tissue sparing and as this compromise is patient individual,
it is difficult for human planners to find this compromise. Craft et al. introduced
multicriteria optimization (MCO) into treatment planning to give the planner the
opportunity to explore the trade-offs for an individual patient by a real time nav-
igation of the pareto surface [49]. The pareto surface is represented as a linear
combination of several pre-calculated plans, this assumes that the underlying op-
timization problem is convex, because only then the pareto surface is convex and
hence the linear combination of two plans leads to a feasible plan. Strictly speaking
the linear combination of two pareto optimal plans is just an approximation of the
pareto surface, nevertheless if there is a sufficient and well distributed number of
pareto optimal plans it is a close approximation. Later this approach was enhanced
to non-convex problems like beam angle selection by navigating multiple pareto
surfaces [50]. This idea of pareto-front navigation was commercialized in the TPS
RayStation (RaySearch Laboratories AB, Stockholm, Sweden). Strictly speaking
the pareto-front navigation is not an automatic planning approach, but it gives the
human planner the opportunity to explore different trade-offs for individual patients
and thereby helps to define the best compromise between PTV and OAR sparing.
Machine learning and Deep learning
Knowledge based planning is used to predict feasible DVH constraints for novel
patients using the knowledge about previously treated patients. Afterwards, the
predicted DVH constraints are used as planning constraints in the optimization.
McIntosh et al. introduced an approach which is based on machine learning and
radiomic image features and estimates dose-per-voxel [51–53]. The dose to voxel-
feature relationship observed in similar patients is derived from a database of previ-
ously treated patients and is used as a basis. Thereby the dose-per-voxel is predicted,
which can be used as a spatial dose objective in a voxel-based dose mimicking opti-
mization to convert predicted dose into a treatment plan [52]. This approach needs
to learn the relationship between clinical dose distributions and image features char-
acterizing patient geometry. During a second learning phase, a model that is able
to select the correct atlas for a novel patient needs to be trained. When the dose for
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a novel patient is predicted, it needs to be transferred into a clinical plan. McIntosh
et al. proposed to use voxel-based dose mimicking for this purpose [52]. The goal
of the dose mimicking is to translate the predicted dose into modulated beams or
arcs, which need to adhere to the restrictions from the beam model, e.g. maximum
amount of MU, minimal segment size or gantry rotation speed. The dose distribu-
tions used in the training phase are used to establish objectives and weights for the
dose mimicking. Therefore the original dose distributions are compared to the mim-
icked dose distributions with different parameter settings. The full pipeline from
dose-prediction to treatment plan was tested successfully for 12 head and neck cases
[52], whereas the dose-prediction showed its applicability for various treatment sites
such as brain, prostate, lung and rectum [53].
Another knowledge-based planning approach was recently introduced by van der Bijl
et al., who proposed that a model can be used to predict pareto-fronts of planning
parameters on the basis of the planning CT scans and annotated structures [54].
The pareto-fronts of planning parameters are generated by automatic planning of
42 plans for each patient in the training cohort with the iCycle planning approach.
The plans are generated using different wishlists reflecting different clinical priori-
ties. The pareto-front is then approximated by fitting a parametrized convex surface
to these sample plans. Geometric features are then extracted from the delineated
structures and used as input parameters for the model. The model was tested for 23
patients in the validation cohort, and the fit parameters for the pareto-front could be
predicted within 1Gy difference. The proposed approach for prediction of patient
individual pareto-fronts is treatment site and technique specific and its principle
applicability was demonstrated for simplified prostate cases. Nevertheless it should
be mentioned that the proposed super ellipsoid parametrization of the pareto-front
is only valid for convex pareto-fronts. This approach does not give a treatable plan,
but it provides a human planner with insights regarding the treatment planning
trade-offs. The predicted planning parameters, which reflect the favorable trade-off,
might than be used in a treatment plan optimization.
Deep learning also recently entered the field of RT treatment planning. In a first
step, a prediction of achievable patient individual 3D-dose distributions is needed
[55, 56]. Images with delineated targets and OARs of previously planned cases are
used as inputs and the related dose maps as outputs of the database. For rela-
tively consistent cases such as prostate treatments, a precise prediction of high-dose
regions, especially for the PTV is feasible. But low-dose regions are challenging, be-
cause they are highly dependent on patient anatomy and treatment properties, such
as beam-angles in step and shoot IMRT [55]. Nevertheless, a predicted 3D-dose dis-
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tribution is not yet a treatable plan. To obtain clinically usable RT treatment plans,
the voxel-wise 3D-dose distribution might be used for a voxel-wise dose-optimization,
as recently proposed by Fan et al. [57].
Prediction of 3D-dose distributions is promising, but one should be aware that such
models depend on the quality of the manually optimized dose distributions which
are used to train the models. Chen et al. and Fan et al. showed first promising
results for step and shoot IMRT [56, 57]. By now these deep learning algorithms are
good in predicting the high dose regions, but they have some problems to correctly
predict low dose regions. This might be due to the different patient anatomies and
treatment properties. The prediction of VMAT treatments also remains challenging.
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1.5 Statistical Optimization techniques in RT
treatment planning
The optimization algorithms that are currently used in treatment planning normally
make use of differential information to steer the optimization in the right direction
in the search space and therefore expect convex constrained functions and a sin-
gle global optimum. Nevertheless, the more complex treatment planning problems
get, the more complex the search space might get, and to address this challenge
other optimization techniques were developed. Two statistical and nature-analogous
techniques which already showed promising results are optimization with genetic al-
gorithm (GA) [58, 59] and PSO [60–64]. Both optimizations rely on the usage of
random numbers and therefore explore the search space more or less randomly. This
is especially promising if the search space includes several local optima or disconti-
nuities.
Optimization with GA adopts the principle of survival of the fittest. Fiandra et
al. used a GA to optimize the serial maximum constraints in prostate cases [58].
Therefore pairs of rectum and bladder serial constraints are initialized randomly
and the plans are calculated accordingly. Afterwards the plans are compared. The
best plan for the optimization round is kept, whereas all other combinations inter-
change rectum or bladder constraints, respectively. Additionally, constraints might
randomly change their constraint value (mutation), employing the nature analogous
principle of survival of the fittest. This process is repeated several times and in each
iteration the best plan is saved. After the optimization is completed, the final best
plan is chosen out of all iterations’ best plans. The applicability of this concept for
different prostate RT treatments was proven by a large multi-center study with 10
different institutions and 100 patient cases [59].
Another nature-analogous, statistical and global optimization technique is parti-
cle swarm optimization (PSO), which is based on the idea of the social behavior of
swarms of fish or birds. A swarm contains simple individuals which are able to share
information and thereby compete for best positions in the search space. The best
position is defined by a predefined evaluation function, also called fitness. Further
details about PSO can be found in the material and methods sections 2.1.
As PSO is relatively simple to implement and is suitable for large scale non-convex
problems due to its statistical nature and global optimization, it quickly gained at-
tention and is applied in many different fields, e.g. truck scheduling [65], design of
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an urban transport system [66], determination of nano-particle shapes to determine
absorption coefficients [67] and in medical engineering [68]. As inverse RT treatment
planning is a large-scale optimization problem, PSO was proposed for planning of
external beam RT treatments as well as for brachytherapy.
In IMRT beam angle selection is crucial for plan quality, therefore Li et al. pro-
posed PSO for beam-angle selection in IMRT [60]. Modiri et al. introduced PSO
to the field of 4D-conformal lung stereotactic body radiotherapy (SBRT), where
the fourth dimension is time with respect to the target respiratory movement [61–
63]. PSO is used to set aperture weights for pre-configured apertures. Further-
more Riofrio et al. presented approaches for GammaKnife radiosurgery and high
dose rate (HDR) prostate brachytherapy [64]. For radiosurgery PSO determines the
positions of the spherical high-dose volumes and the beam-on times, whereas for
HDR prostate brachytherapy needle positions and dwell-times need to be optimized.
Yang et al. proposed a PSO based planning to automatically set weighting factors
in multi-objective optimization [69]. The positions of the particles are determined
as sets of weighting factors, thereby each particle represents a plan. The quality
of the plans is determined by three evaluation functions which are changed over
time. The first evaluation function ensures the target coverage to dose, the second
one should minimize high dose to the OAR while keeping the previously established
level of PTV dose, and the last evaluation function is then used to reduce low doses.
Each evaluation function incorporates key points from the DVH. After evaluation
by the appropriate function the weighting factor for each particle is updated using
information about the best evaluated plans.
In inverse RT planning, as it is state of art the for all IMRT treatments, many
different constraints and objectives need to be balanced. Due to the complexity of
the optimization problem it is nearly impossible to predict the impact of a variation
of constraints, therefore human planning is trial and error based. With PSO the
process will still be trial-and-error, but in difference to a human planner more com-
binations are examined, unusual combinations get a chance, due to the statistical
nature, and by using a clearly defined plan quality measure the comparison of two




1.6 Aims of this thesis
Automatic treatment planning is essential for RT to overcome the problems of time-
consuming and ineffective planning. Thus, automatic treatment planning helps to
address the dependence between time allocated to the task, the planner’s experience,
and the quality of the plan. A further advantage is that automatic planning can
facilitate a fast and reliable adaption of treatment plans to daily chaining anatomy
and setup errors.
Against this background the aim of this thesis is to implement particle swarm opti-
mization (PSO) as an automatic RT planning tool. Thereby the pareto-surface can
be efficiently navigated and clinically optimal treatment plans can be generated for
individual patients.
The implementation needs to be validated with regard to the convergence ability to
the global optimum and effectiveness of covering the search space.
The applicability of this approach is demonstrated with relatively simple post-oper-
ative prostate cases. For 10 cases, PSO treatment plans are generated automatically
and compared to manual plans. The PSO plans should be as good as or preferable
better than the manual plans.
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2 Materials and Methods
The methods described in sections 2.1 Particle Swarm Optimization and 2.2 Plan
Quality Score are partially published in
Künzel L.A., Leibfarth S., Dohm O.S., Müller A.-C., Zips D., Thorwarth D.:
"Automatic VMAT planning for post-operative prostate cancer cases using par-
ticle swarm optimization: A proof of concept study", Physica Medica, Volume
69, January 2020, pp. 101-109, 2020. DOI: 10.1016/j.ejmp.2019.12.007
and referenced as [70] in this thesis.
2.1 Particle Swarm Optimization
2.1.1 Background
PSO is a nature-analogous optimization technique with collective, iterative and sta-
tistical characteristics and is used to solve non-linear problems. It was first intro-
duced by Kennedy and Eberhart in 1995 [71] and is inspired by the behavior of
swarms as flocks of birds or schools of fish. Thus relatively simple individuals are
able to solve complex problems, such as searching for roosting places or food, if
they cooperate and share information in a swam of I individuals. This can be trans-
ferred to an optimization problem where the individuals explore a search space for
an optimum position and share information about positions in this search space.
By comparing information about the best position amongst all particles to the po-
sitions it visited, each particle alters its own position in the search space. Particles
are attracted to the best position but also try to explore new positions. Thereby
the search space is explored by the particles. To adopt this idea for any kind of
optimization problem, four prerequisites have to be met:
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Position information
The position in the search space for each individual needs to be known and is
therefore determined by the vector xi,d. Where i is the number of the particle
out of r1, Is and d the number of generations out of r1, Ds. The vector xi,d
gets as many entries as the N -dimensional solution space has dimensions.
Quality assessment
Each candidate position has to be evaluated by a function to determine the
quality, also known as fitness, to compare competing positions xi,d in the search
space.
Memory
Each particle memorizes the best position pbest,i, which it visited so far in the
search space, and the according fitness value. This is a personal attraction
point for each particle. Furthermore each particle has to memorize the last
position update vector, also called inertia.
Shared information
All particles of a swarm share their personal best position. By comparing
these personal best positions, a global best position gbest is determined, which
is then an attraction point for all particles of the swarm in the subsequent
generation.
By combining this shared knowledge, iterative position updates for each particle are
calculated, according to equations (9) and (10):
xi,d  xi,d1   ∆xi,d (9)
here ∆xi,d denominates the relocation vector for each particle i, which is calculated
by the sum of three different components, the inertia component T , the cognitive
component M and the social component S:
∆xi,d  T  M   S (10)
The first component T is called inertia or nostalgia and is derived from the inertia
weight ω and the previous relocation vector vi,d1, c.f. equation (11). The inertia
weight was first introduced in 1998 by Shi and Eberhart [72] to control exploration
and exploitation abilities of the particle swarm. Exploration here means the ability
of the optimization to scout the whole search area or –visually speaking– to leave a
local optimum. In contrast, exploitation means the ability to scout a small area more
26
2 Materials and Methods
precisely or –again visually speaking– climbing a founded maximum. The inertia
weight determination is a critical part of the PSO implementation, as it affects the
ability of the PSO to converge and also the speed of the convergence. A faster
convergence is eventually associated with a poor exploration of the search space
and hence has the hazard to be trapped in a local optimum, whereas over-exploring
might impede the PSO from settling on the optimum. Shi and Eberhart proposed
to set a constant inertia weight between 0.9 and 1.2 to balance exploration and
exploitation. Based on the idea that the search should start global and settle down
to an optimum, the idea of linearly decreasing inertia weights was also proposed
[72, 73]. There have also been attempts to use non-linear reduction and even more
complex schemes [74]. Adaptive inertia weights were also introduced, where the idea
is to monitor the behavior of the swarm and adapt the inertia weight during the
PSO [75].
T  ω  vi,d1 (11)
The second component M evaluates the distance between the actual position xi,d1
and the particle’s own best position pbest,i during the whole search history, c.f. (12).
As this component is related to the particle’s best position, which can be seen as
the particle’s memory, it is sometimes called the cognitive component.
M  c1  ζ  ppbest,i  xi,d1q (12)
The third component S is related to the shared information of the swarm and is
therefore referred to as the social component. It evaluates the distance between the
actual position of the particle xi,d1 and the global best position gbest ever seen by
a particle of the swarm.
S  c2  ξ  pgbest  xi,d1q (13)
To introduce the statistical nature to the PSO, the cognitive and the social com-
ponents are weighted by two vectors of random numbers ζ and ξ. Additionally,
the cognitive and social components are weighted by optimization constants c1 and
c2, which should balance the two components. Kennedy and Eberhart proposed to
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weight them equally and set them to c1  c2  2 [71].
When all particles have updated their position once a complete iteration was exe-
cuted, this is called ’a generation’ in PSO. All optimization parameters needed for








Table 1: Summary of PSO parameter symbols and meanings with related explanations for RT treatment planning and parameter values for the PSO
implementation used for post-operative prostate cases. Reprinted from [70] with permission from Elsevier.
Symbol Meaning Explanation Parameter values
postoperative
I Number of particles A particle is a set of planning constraints,
translating to a plan/dose distribution
I  30
N Dimensionality of the
solution space
Identical to number of planning constraints N  3
D Number of genera-
tions
Number of PSO iterations DMax  100
ζ, ξ Vectors of random
numbers
N -dimensional vectors, with components
each sampled from the interval [0,1]
[0,1[
c1, c2 Optimization con-
stants
To balance relocations, these constants are
held fixed during the whole optimization pro-
cess
c1  c2  2 [71]
ω inertia weight Balances exploration and exploitation. This
parameter is adapted during optimization
process.
ω  1.4 in generation 0-9, reduced by 0.2
every 10th generation until 0.2 is reached in
generation 50
xi,d Current position of
particle i in generation
d
Vector of planning constraints in the N -
dimensional solution space
vi,d Relocation of particle
i in generation d
N -dimensional relocation vector
pbest,i Previously best posi-
tion of particle i
Position of so far best-scored plan of particle
i
gbest Global best position Best-scored position reached so far over all
particles
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2.1.2 Implementation of PSO for RT Treatment Planning
To realize a PSO implementation for RT treatment planning a particle is interpreted
as a plan and its position is represented as a vector of N different planning con-
straints. After initializing the plans randomly, they are calculated by our in-house
TPS Hyperion. To judge the quality of competing plans and to determine the best
plans, a fitness measure is needed for the implementation, therefore a so called plan
quality score (PQS) is introduced, for details see section 2.2. Using this PQS the
global and particle’s individual best positions gbest and pbest,i are assessed and the
position update is calculated using equations 9 and 10.
The PSO and the manipulation of the TPS Hyperion input files are implemented
in separate Python 2.7.3 scripts. A bash-script is used to control the interaction
between TPS and PSO, as illustrated in the schematic flowchart in figure 13. The
bash-script and the python scripts can be found in Appendix A. The PSO starts
with random initialization of the particle positions, i.e. constraint combinations of
a plan. This initialization is implemented as separate Python script which also ma-
nipulates the constraint values in the respective lines in the TPS Hyperion input
file, which formulates the optimization problem. Consequently, all constraint and
objective types and values are defined and assigned to the appropriate PTV or OAR.
Additionally, this file also contains all other optimization and sequencing parameters
such as minimal MU values per segment, minimal segment size, number of arcs and
others.
After all plans have been initialized, the constrained optimization for the first parti-
cle starts. Once plan calculation is finished, TPS Hyperion automatically saves the
dose and DVH files, where for each ROI the DVH information is stored. This DVH
is then in a next step accessed by the script scoring.py, which calculates the total
PQS for the plan. Afterwards, the script get_pbest.py compares the actual PQS
to the so far reached best PQS of the particle, and the best position is updated if
necessary. At this point the first generation for the first particle is finished and the
first generation for the second particle starts with the constrained optimization in
the TPS Hyperion. After the first plan calculation for all I particles, the swarm’s
best position is accessed by the script get_gbest.py and the position relocation vec-
tors for each particle are calculated according to equations (9) and (10) by Python
script update_velo.py. This script also manipulates the TPS input file by replacing
the constraint values accordingly. At this time point, the first generation of PSO is
completed and the following generations are conducted accordingly until the maxi-
mum number of generations is achieved.
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Create Hyperion DVH-files 
repeat  for 
next 
particle 
Constrained optimization in TPS Hyperion 
scoring.py 
Evaluate plan quality (PQS) 
get_pbest.py 
Compare actual PQS to previous 
best PQS and update particle’s 
best position 
Initialization.py 
Initialize I particles with 
N constraints 




Set actual swarm’s best position 




Final treatment plan 
calculation 
using constraints of 
global best position 
Yes 
Figure 13: Flowchart of the procedure of the PSO, which is monitored by a bash-script.
I number of particles/plans, N number of constraints per plan, D number of generations,
PQS plan quality score.
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2.1.3 Patient data
To illustrate the applicability of PSO for automatic VMAT planning the procedure
was tested on n  10 post-operative prostate cancer cases. All cases were chosen
randomly from our clinical database and have clinical manually optimized plans for
the same treatment machine. Patient data was pseudonymized as cases PC01 to
PC10. The treatment concept included a prescribed EUD of 66Gy to the PTV
and contains rectum and bladder as main OARs. For the OARs, serial constraints
taking EUD and an exponent as parameters were used. For details about serial con-
straints, see section 1.3. In the TPS Hyperion, handling overlap between PTV and
OAR structures is possible. Normally, PTV is defined at first in the TPS input file.
Thus, by definition voxels belong to the PTV and are ignored for OAR constraints.
But it is possible to include compromised voxels to the OAR constraints explicitly
if needed. This is especially helpful to control overdosing in the intersection area.
For example, in prostate cases rectum and PTV normally overlap as the prostate
is in contact with the rectal wall. As the PTV concept considers setup errors, the
PTV for the prostate is bigger than the prostate itself and will therefore compromise
the rectum. Nevertheless, a slight overdosing, which is in principle accepted for the
PTV, should not be in the intersection between PTV and rectum. The first rectum
constraint, with exponent kr1  12 and optimizing all voxels, was used to control
high doses. A second serial constraint which only applies to voxels of rectum which
were not intersected by the PTV, with exponent kr2  4, was used to control middle
and low dose regions. For the bladder, a serial constraint optimizing all voxel with
exponent kb  8 was used to control intermediate and high doses. For all serial
constraints, the EUD was the parameter to be chosen by the PSO. The exponent
was not optimized. The search space for this three serial constraints is 3 dimensional
and the position of each particle (plan) is described by a vector taking the three
EUD values as entries.
To initialize the particles, a plan with non-binding rectum and bladder constraints
(Cj = 66 Gy) was calculated to estimate a minimum feasible OAR sparing. Therefore
a specific feature in the TPS Hyperion was used, where constraints are minimized
further than the defined threshold, as long as this does not harm the PTV objective
or other OAR constraints. This is subject to a barrier-penalty multiplier method,
which is implemented in TPS Hyperion [76]. The thereby reached dose effects Gj
were then used as the center of the initialization space, which spreads out by 5 Gy
for each dimension. Particles were randomly initialized within this range. The relo-
cation vectors ∆xi,d were also initialized randomly for each entry from the interval
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[-1,1].
The swarm contained I  30 particles (plans) per generation and the termination
criterion was set to DMax  100 generations. For a summary of all parameters see
table 1.
To generate random numbers during the initialization and also for the weighting
vectors ζ and ξ, the Python random module was used. The module is by default ini-
tialized by date and time, and gets reinitialized with every call of a python script.
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2.2 Plan Quality Score
As PSO requires the identification of global (gbest) and local (pbest,i) best plans, it is
necessary to determine criteria for the comparison of treatment plans. This compar-
ison has to be fair, reproducible, needs to identify one plan as the superior one, and
related to the corresponding clinical considerations. To measure the particle per-
formance a plan quality score (PQS) was introduced, which was adapted from the
DVH parameters defined in our institutional standard operating procedure (SOP).
The PQS needs to be redesigned for specific treatment sites and treatment intents.
For the post-operative prostate cases a total of eight different DVH parameters were
used to evaluate the quality of a treatment plan. A summary of the PQS parameters
used for PQS assessment is listed in table 2. The table also contains an explanation
for the clinical considerations that were monitored by these parameters. The prin-
ciple idea was to reward adherence and to penalize violation. For the PTV, three
DVH parameters were evaluated for PQS definition concerning EUD, D2% (near
maximum dose) and D98% (near minimum dose). Schematic drawings illustrating
how the achieved dose parameters for the PTV were converted into PQS are pro-
vided in figure 14.
Figure 14: Schematic illustration of the plan quality score (PQS) for PTV parameters
equivalent uniform dose (EUD), D98% near minimum dose, D2% near maximum dose, L limit
defined in standard operating procedure (SOP)). Reprinted from [70] with permission from
Elsevier.
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Figure 15: Schematic course of the plan quality score (PQS) related for the OAR parameters.
L limit, B bend. Reprinted from [70] with permission from Elsevier.
Rectum and bladder were identified as main OARs. For the rectum D2%, V60Gy
and V40Gy, and for bladder D2% and V60Gy were evaluated. The associated DVH
parameters are summarized in table 2. As the volume constraints V40Gy and V60Gy
are highly related to the individual patient anatomy, a plan with non-binding OAR
constraints (Cj  66Gy) was calculated beforehand to estimate a minimum possible
OAR sparing. The reached dose effects Gj (c.f. equation 7 in section 1.3) were then
used to introduce an additional bend in the PQS equaling the reached dose effect
Gj, c.f. figure 15. This bend should guide the PSO for optimal OAR sparing by
penalizing the exceedance of this bend, nevertheless the penalization is not as strict
as the exceedance of the limit defined in the institutional SOP. For plans staying
below the bend, the PQS offers a reward by applying positive points.
The maximum reward for each DVH parameter was limited to one scoring point,
except for PTV parameters D2% and D98% which only penalize violation (c.f. figure
14 b and c). For plans which fulfill all PTV and rectum or bladder goals, an extra
reward of 5 points each was applied. Hence a theoretical maximum score of PQS=16
could be reached in this study.
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Table 2: Summary of DVH parameters used for plan quality score (PQS) and plan evaluation.
All parameters are taken from our institutional SOP (DP prescribed dose 66 Gy). Reprinted




PTV EUD = 66.0 Gy Dose prescription DP ,
minimum requirement EUD = 65 Gy
D98% > 62.7 Gy (95% DP ) adapted from ICRU Reports 62 and 83 [77, 78]
D2% < 70.6 Gy (107% of DP )
Rectum D2% < 66.0 Gy ICRU 83 [78]
V40Gy < 80.0% 92% of patients without Grade 2+ GI toxicity
[79]
V60Gy < 40.0% To prevent moderate/severe toxicity (any end-
point) [80]
Bladder D2% < 66.0Gy ICRU 83 [78]
V60Gy < 50.0% Institutional standard adapted from
QUANTEC (V65%   50% Grade 3+ tox-
icity)[81]
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2.3 Analysis of convergence
The ability to converge is crucial for a PSO: it means that the entire swarm settles
down at a final best position. The convergence of the swarm might also be used as
a termination criterion for the optimization. One option to assess the convergence
graphically is to plot the mean, minimum and maximum constraint values of each
swarm generation over the course of optimization. This could be the actual position
of each particle or the personal best position (pbest), nevertheless this is a qualita-
tive analysis. For quantitative interpretation, the relative difference of the mean
constraint value between two subsequent generations can be calculated:




The mean value stabilizes if all individual particle stabilize. However, this does not
necessarily mean that all particles reach the same value. Therefore the gap between
maximum and minimum constraint value might be analyzed as a second indicator.
As a third indicator for convergence the course of the position update, calculated in
equation 10, is analyzed. As described in equation 10, the relocation vector contains
three different components: inertia T , the cognitive component M and the social
component S. To further analyze the mean contribution T̄ pdq of each component
to the mean relocation ∆x̄pdq in each generation d during the course of PSO, the
relative contribution of each component in one generation to the absolute mean
relocation vector is calculated. Equation (15) defines the calculation of the relative
contribution of the inertia componentWT pdq. |∆xi,d| is the modulus of the relocation
vector of particle i in generation d and |Ti,d| is the modulus of the inertia component
of particle i in generation d, therefore the sign of the components is neglected. I
is the number of particles. The relative contributions WM and WS of the cognitive


















The different components, especially inertia, are crucial to the exploration and ex-
ploitation ability. Inertia describes the effort of the individual particle to keep its
own traveling direction. This means that the higher the inertia component is, the
less the particle is attracted to the swarm’s and its own best position. Therefore a
high inertia promotes the exploration of the search space and a good exploration is
preferred in the beginning of PSO, whereas during the course of the optimization
exploitation should increase. Hence the inertia weight is lowered during the course
of PSO to decrease the influence of inertia to the relocation. Therefore it is expected
that the contribution of the inertia component to the relocation is high in the be-
ginning and decreases over time.
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2.4 Analysis of exploration and exploitation
effectiveness
The ability of the swarm to explore the entire search space is crucial for the success of
PSO. Exploration means that the entire search space is evaluated and hence visited
by at least one particle. As aforementioned, the PSO is tested with relativity simple
treatment plans for post-operative prostate cancer cases, where the combination of
three serial constraints is optimized. Therefore the search space is 3-dimensional
and each constraint can take an EUD value in the interval [10Gy,66Gy]. The lower
limit was not set to 0 as this would probably cause infeasible constraint combinations,
nevertheless a constraint of EUD=10Gy may also be too strict. In our study, the
upper limit was set to EUD=66Gy as this was the prescribed dose to the tumor








































Figure 16: 3D plot of the search space. As 3D plots are difficult to comprehend, the plot
can be divided into 2D plots by projecting the third dimension to the boundary of the search
space. If we look at the plain representing constraints 1 and 3, one position is obliterated
because of the projection. To prevent this, all 3 possible combinations of constraints have to
be always taken into account.
To evaluate and get an impression of the constraint combinations, i.e. positions vis-
ited during the course of PSO, the search space was visualized. As the search space
is three dimensional, 3D-plots were used. But as 3D-plots are hard to evaluate,
the positions were additionally projected to the 2D-planes at the boundary of the
39
2 Materials and Methods
search space. This 3D-plot with 2D-projections of the particles’ positions is exem-
plary shown in figure 16. In order to not loose the information of the third dimension


















Figure 17: Graphical representation of the 3D-search space divided into eight sub-search
spaces, represented as octants. The position of the global best position gbest in the corners of
the sub-search spaces is marked as asterisk *.
To assess the exploration ability, the distance between the final best position, e.g. the
combination of constraints used to calculate the PSO plan, and each position visited
during the optimization by a particle is calculated (equation 18). If only distance
would be evaluated, the spatial information would be discarded. Therefore the
search space was divided in eight sub-search spaces. These octants are defined such
that the particle’s final best position was in the center, where all eight cubes touch
each other. For a graphical representation, see figure 17. Then a frequency polygon
of the distance to the final best position is plotted for each sub-search space. Fre-
quency polygons offer the same information as histograms, but are easier and more
comprehensible if several polygons are summarized in one plot.
|xi,d| 
b
pC1i,d  C1g_bestq2   pC2i,d  C2g_bestq2   pC3i,d  C2g_bestq2 (18)
In the beginning of the PSO a good exploration ability is important, whereas with
increasing number of generations exploitation ability becomes more important. Ex-
ploitation means that the region around the identified global best position should
be scanned more precisely, because a slightly better combination can potentially be
found nearby. Therefore the distance between the final best position and the actual
position was analyzed with respect to the generation number. For this, generations
were grouped in blocks of 10 subsequent generations starting with generation 0 to
9. Again, frequency polygons were plotted for evaluation.
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2.5 Comparisons of manual and PSO plans
All manual plans in this study were retrospectively taken from the clinical patient
database. Patients cases with the same prescription scheme and treatment intend
were chosen. No extra time or inputs except from the planning criteria defined in
the in-house standard operating procedure (SOP) were used when preparing the
manual treatment plan for each patient. The manual plans were not all created by
the same physician and planner, as there is a rotation of staff in clinical duties. The
PSO plan for each patient was generated as described in section 2.1. In difference
to the manual plans, there was no time restriction. The PQS was established in
an iterative process. Some of the cases were planned several times to find a PQS
definition which ensures planning restrictions according to our in-house SOP. But
for all 10 cases, only the PSO plan generated with the PQS described in section 2.2
is presented and compared to the manual plan in this work. Nevertheless PSO is
based on the same criteria as defined in the SOP, which were also taken into account
during the manual planning process.
2.5.1 Dosimetric comparisons
As for each patient case, a manual and a PSO plan exist, the dosimetric comparison
was made between the two plans for each individual case. The dosimetric and volu-
metric criteria used for comparison are directly related to the plan quality criteria
defined in the SOP. The evaluated dosimetric parameters are the same as used for
the PQS definition, c.f. table 2, and are presented as boxplots to evaluate the spread
over all ten cases via quartiles.
2.5.2 Statistics
A Wilcoxon signed rank test with Bonferroni correction was carried out using the
software package R (Version 3.5.1)[82]. Differences between manual and PSO plans
resulting in p-values smaller than 0.05 were considered statistically significant. A
Wilcoxon signed rank test was deemed appropriate due to the non-normally dis-
tributed nature of the tested dosimetric and volumetric parameters and due to the
paired test situation, as there was a manual and a PSO plan for each patient case.
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Due to the multiple testing for several dosimetric and volumetric criteria, a Bonfer-
roni correction was applied.
2.5.3 Comparisons of dose-volume-histogram (DVH)
DVHs for pairs of manual and PSO plans were compared visually. For a better
comprehension of overall differences in DVHs of manual and PSO plans, a DVH
spread was plotted. The plot was generated by determining minimum and maxi-
mum volume fraction for dose bins over all individual DVH of the respective cohort.
Therefore the plotted area contained all individual DVH. A narrow band would
indicate a lower inter-patient variability than a broader band.
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Parts of the results presented in section 3.1 Analysis of convergence ability and
section 3.3 comparison of manual and PSO plans are published in
Künzel L.A., Leibfarth S., Dohm O.S., Müller A.-C., Zips D., Thorwarth D.:
"Automatic VMAT planning for post-operative prostate cancer cases using par-
ticle swarm optimization: A proof of concept study", Physica Medica, Volume
69, January 2020, pp. 101-109, 2020. DOI: 10.1016/j.ejmp.2019.12.007
and referenced as [70] in this thesis.
In this thesis, an automatic planning approach based on PSO was successfully im-
plemented and tested for 10 post-operative prostate cancer cases. For 9 out of 10
cases PSO plans reached clinical quality and were comparable to manual plans. In
the following results sections the PSO implementation is analyzed concerning the
convergence ability and also the balance of exploration and exploitation. Afterwards
the automatically planned post-operative prostate cases are presented and compared
to the manual plans.
3.1 Analysis of convergence ability
In this study, the termination criterion was set to a maximum of 100 generations.
This is the simplest termination criterion, but it may not be the most efficient one.
Depending on the case the PSO may find the global optimum earlier or later. In the
first case the final generations will not enhance plan quality but waste computation
time, in the latter one a better plan may have been found. The ability of the
PSO to converge against an optimum is patient specific and also determined by the















































































Figure 18: Course of best positions mean, minimum and maximum rectum constraints a)
and b), bladder constraint c), PTV EUD c) and total PQS (d) for case PC03, amounted from
[70].
PSO for the 10 planned post-operative prostate cases, the convergence ability was
further analyzed.
Figure 18 visualizes the evolution of the particles’ best positions pbest showing mean,
maximum and minimum rectum and bladder constraints, PTV EUD and total PQS
of the 30 particles for each generation for case PC03. The constraints in figure 18 a)
to c) started with a small search space, which was determined by the initialization.
Then the search space was explored, which means that the particles explore the
entire search space. After generation 50 the particles started exploiting a much nar-
rower part of the search space. They seemed to stabilize after generation 70, which
is in line with the stabilization of the total PQS figure 18 e). The PTV EUD which
is depicted in figure 18 d) stabilized at 65.6Gy, which is less than the prescribed
EUD of 66Gy. This reflects a meaningful compromise between PTV dose coverage
and OAR dose sparing. The total PQS is intended to converge against a maximum,
for the visualized example this was accomplished (figure 18 e) and it appeared to
stabilize after generation 80. The update of the global best value (gbest) is also vis-
ible in the graph as steps in the maximum PQS. But due to the spread between
maximum and minimum constraint values, it is also evident that, not all particles
are close to the final best position, especially for the bladder constraint.
For further analysis of the convergence ability for all 10 cases, the relative differ-
ence in mean constraint values between subsequent generations was calculated. The
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criterion was set to a relative difference of less than 0.1 % and is visualized in
figure 19. For all 10 cases and all constraints the relative difference in mean values
stabilized and fulfilled the set criterion. For all cases the rectum C1 and bladder C3
constraint seem to have stabilized earlier than the second constraint for rectum C2.
For some cases, the difference criterion for constraint C3 was even only fulfilled in
the last generations (see figure 19 a), b) and f)) for cases PC01, PC02 and PC06).
Also in early generations, the mean value of the global best position can stabilize for
a while, this is probably because the best position of the particles was not updated in
every generation, especially in the beginning of the PSO, where weak combinations
of constraints were also explored. Nevertheless, as was also mentioned for the plot
in figure 18, the sole evaluation of difference in mean values does not reflect the dis-
tance between minimum and maximum. Therefore the distance between maximum
and minimum constraint value can be used as a second criterion. For the rectum
constraint C1 all cases reached the criterion of a distance less than 1Gy between
minimum and maximum. For the rectum without PTV constraint C2, the criterion
was violated in all cases. Nevertheless, for some cases like PC01, PC03 and PC06
it was nearly reached (see figure 19 a), c), f)), but for others like PC02 and PC05
it was obviously missed (figure 19 b) and e)). For the bladder constraint C3 the
criterion was fulfilled in 4 out of 10 cases. For the other cases such as case PC03 in
figure 19 c) it was sometimes nearly met, while in others such as cases PC04 and
PC09 it was clearly missed. There was no clear connection between the convergence
of the different constraints, therefore to access the convergence of the PSO all opti-
mized constraints needed to be evaluated independently. Nevertheless, even if one
constraint converges and is stable over several generations, other constraints may
need more generations until full convergence is reached.
As described in equation 10 the relocation vector contains three different components:
inertia T , the cognitive componentM and the social component S. For PC03 the rel-
ative contribution of each component to the relocation vector was further analyzed
(see figure 20). As expected, the inertia component had the highest relative con-
tribution in the beginning of the PSO, with decreasing importance throughout the
optimization. The cognitive and the social component increased during the course of
PSO. As the inertia component was the dominating part in the relocation vector in
the beginning of PSO and became less important during the course of optimization,
the reduction of the inertia weight ω during the PSO gave the expected result for
the position updates. During the promotion of inertia in the beginning, the particles





















































































































































































































































































































































































Rectum |C1,mean| Rectum |C2,mean| Bladder |C3,mean|
Rectum ΔC1 Rectum ΔC2 Bladder ΔC3
Figure 19: Visualization of termination criteria relative difference of subsequent generations
of less than 0.1% and difference between maximum and minimum constraint less than 1Gy






















































































































 inertia T cognitive component M social component S
Figure 20: Analysis of relative contribution of the T inertia, M cognitive and S social
component to the relocation vectors of the three optimized constraints over the course of PSO
for PC03.
position, which is important to guarantee the exploration ability of the swarm.
Figure 20 also shows that the cognitive and the social component can outweigh the
inertia component. This is probably the case if the actual particle position is already
far away from the particle’s and swarm’s best position. In that case, the large dis-
tance between particle and best positions will result in large relocation contributions
by the cognitive and social components.
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3.2 Analysis of exploration and exploitation ability
For two exemplary cases (PC03 and PC08), all positions visited in the search space
during PSO were plotted (figures 21 and 22). The search space seems to be suffi-
ciently explored, as all regions were visited at least once. The upper boundary was
visited extremely often, which may be due to the handling of particles which hit the
boundary of the search space. A further reason for this observation may be the fact
that the final optimum often does not lie in the center of the search space, but is
instead frequently located much closer to the upper boundaries. Consequently, the
lower boundary was rarely visited, especially for the rectum and bladder high-dose
constraints (C1 and C3). Nevertheless it is visible from the PQS that only poorly
scored constraint combinations were found in this region, therefore it was not ex-
plored more deeply. The mid-dose constraint for the rectum (C2) is expected to
take lower EUD values than the high-dose constraint. For that constraint, the lower
boundary was also explored more often. The region around the final best-position
seems to be most promising and was well exploited for both cases.
As mentioned before, the TPS Hyperion reduces non-binding constraints automat-
ically during plan calculation. Therefore there may be a difference between the
position defined by the constraint Ci value and the actual reached dose-effect Gi.
This may cause a misinterpretation of the position. To further evaluate this, in
figures 21 and 22 e) to h) the particle positions defined by the achieved dose-effects
are plotted. Unbinding constraints are expected to occur in the region above the
optimum position. By plotting the positions defined by dose-effects, it appears as
if this region was never visited, which however is not correct. Consequently, to an-
alyze exploration and exploitation ability, both position definitions are needed. It
is noticeable that the lowest scored plans were below the final best position. Above
the final best position, plans scored worse than the final best position, but not as
bad as the lower ones. Nevertheless, the final best position is clearly visible as the
global optimum in the optimization space. In figures 21 and 22 f), where the dose-
effects for the two rectum constraints are plotted, the two tails visible in the lower
left quadrant seem to be characteristic. They might be explained by the interplay
between these two constraints. The C1 constraint is intended to control the high
dose region in the rectum, whereas the C2 constraint controls the intermediate dose
region. But it is obvious that if the high-dose is heavily restricted, the mid-dose
should also be lower. Therefore the combination of a strict high-dose constraint C1
and a loose mid-dose constraint C2 was inherently corrected by reaching a better
dose-effect for C2 than requested. This is also applicable vice versa.
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In figure 23, the search space is plotted including all positions visited by single parti-
cles. The color distinguish particles and again positions are defined by constraints or
dose-effects. It is shown that all particles explored the entire search space randomly
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Figure 21: Positions visited in the search space for case PC03 in 3D and 2D plots. For sub-figures a) to d) position is defined by constraints Cj and
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Figure 22: Positions visited in the search space for case PC08 in 3D and 2D plots. For sub-figures a) to d) position is defined by constraints Cj and




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 23: 3D plots of all positions visited in the search space during the course of PSO for
PC03. The color distinguish the 30 different particles. In sub-figure a) positions are defined
by constraints Cj and in b) by dose-effects Gj .
To further analyze the exploration ability, the search space was divided into eight
sub-search spaces. All sub-search spaces had their origin at the final best position
of the individual cases. A frequency polygon of the distances between all visited
positions and the final best position is plotted in figure 24. As the distance between
actual and final best position is relative, the information for all 10 cases can be
combined in one plot. The frequency polygons for all 8 sub-search spaces followed
the same behavior, the most frequent distance for all sub-search spaces was between
0.0 and 1.0Gy or 1.0 and 2.0Gy. After the peak, the frequencies dropped off im-
mediately and the tail leveled out to the maximum distance. For all 8 sub-search
spaces, there were more particles close to the final best position than far away, indi-
cating a good exploitation. Nevertheless all sub-search spaces also presented higher
distances, indicating particles far away from the optimum and therefore describing
the exploration ability. The maximum distance in all search spaces was on average
44.70Gy (range 31.92 - 52.65Gy). The wide range of maximum distances was due
to the different absolute sizes of the sub-search spaces, as the final best position
was not in the center of the search space. In all 8 sub-search spaces positions close
to the final best position were visited, as indicated by the average (range) mini-
mum distance of 0.01,Gy (0.00 - 0.02Gy). The average median distance was 3.96Gy
(1.51 - 5.46Gy). As with increasing distance to the final best position the sub-search
space gets wider, an average median distance of 3.96Gy compared to the average
maximum distance of 48.43Gy indicates that more particles visited positions close
to the final best position than far away. For details, see table 3. This is again an
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Figure 24: Frequency polygon of the distance between actual positions and final best position
(note the logarithmic scaling). The search space is divided into 8 sub-search spaces, + means
that the constraint defining the actual position is greater than the final best position, - indicates
that it is lower. Therefor in sub-search space 1 (+++) all three constraints values are higher
than the final best position. This represents the upper right front corner in the 3D plots in
figure 21.
Table 3: Minimum, median, maximum and most frequent distance between final best position
gbest and positions xi,d visited during course of PSO for the eight sub-search spaces over all
10 cases.
sub-search space min [Gy] median [Gy] max [Gy] most frequent [Gy]
1 0.00 4.97 31.92 1.0 - 2.0
2 0.01 4.77 44.54 1.0 - 2.0
3 0.01 1.99 49.40 1.0 - 2.0
4 0.01 4.59 42.80 1.0 - 2.0
5 0.01 5.46 44.19 1.0 - 2.0
6 0.01 3.09 52.65 1.0 - 2.0
7 0.01 5.31 45.12 1.0 - 2.0
8 0.02 1.51 46.96 1.0 - 2.0
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The optimization parameter ω was decreased during optimization to promote a
global search, i.e. exploration, in the beginning of PSO and a more local search,
i.e. exploitation, during the end. This behavior is visualized in figure 25, where
frequency polygons as a function of the distance to final best position for 10 groups
of generations are shown. During generation 0 - 9, the frequency polygon is shallow
and the most frequent distance is 8.0 - 9.0Gy. Nevertheless there were also particles
close to and far away from the final best position, as indicated by the minimum and
maximum distances in table 4. Until generation 29 the particles seem to spread out,
as the peak of the frequency polygon is shifted up to a distance of 12.0 - 13.0Gy (see
table 4). The maximum distance was also reached in the beginning of the PSO be-
tween generations 10 and 19. During the course of PSO, the most frequent distances
in the frequency polygons are shifted towards smaller distances and at the same time
the height of the peak increases. This is again an indication for exploration ability
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Figure 25: Frequency polygon of the distance between actual position and global best posi-
tion over all 10 cases (note logarithmic scaling). The data is grouped by blocks of 10 succeeding
generations.
Table 4: Minimum, median, maximum and most frequent distance between final best position
gbest and positions xi,d visited during PSO over the generations.
generation min [Gy] median [Gy] max [Gy] most frequent [Gy]
0-9 0.32 10.18 46.96 8.0 - 9.0
10-19 1.46 18.05 52.65 12.0 - 13.0
20-29 0.79 15.52 47.02 11.0 - 12.0
30-39 0.20 8.99 41.14 5.0 - 6.0
40-49 0.17 3.93 40.57 3.0 - 4.0
50-59 0.00 1.66 41.02 1.0 - 2.0
60-69 0.00 0.95 31.05 1.0 - 2.0
70-79 0.00 0.61 33.08 0.0 - 1.0
80-89 0.00 0.52 28.60 0.0 - 1.0
90-99 0.00 0.47 25.40 0.0 - 1.0
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3.3 Comparison of manual and PSO plans
PSO was able to propose treatment plans for all 10 cases. The PSO was considered
successful if the particle’s best position values stabilized after 100 generations.
9 out of 10 PSO plans were clinically applicable as proposed, one case (PC01) was
of inferior quality. To assess the clinical applicability of the PSO plans, they were
compared to manual plans. To test if PSO and manual plans showed significant
differences, a Wilcoxon signed rank test with Bonferoni correction was carried out
(for details see 2.5.2).
The median (range) PTV EUD was 65.4Gy (64.7 - 66.0Gy) in manual plans and
65.3Gy (62.5 - 65.6Gy, p  1) in PSO plans. The near minimum dose D98% was
comparable for manual and PSO plans with 62.9Gy (61.7 - 63.6Gy) and 62.8Gy
(59.4 - 63.1Gy, p  1), respectively. Also near maximum dose D2% did not show
significant differences, with 67.7Gy (67.4 - 68.0Gy) for manual plans and 67.9Gy
(67.5 - 68.1Gy, p  1) for PSO plans. However, PSO plans presented significantly
improved rectum high dose sparing by better respecting the limit for D2% with
66.1Gy (64.7 - 66.5Gy) compared to 67.0Gy (66.5 - 67.5Gy, p  0.016) for manual
plans. For rectum V60Gy and V40Gy no significant differences between manual and
PSO plans were reported. Manual plans reached median V60Gy of 22.7% (12.0 -
34.7%) and V40Gy of 47.6% (38.5 - 63.5%) and PSO plans median V60Gy of 22.4%
(13.0 - 33.4%, p  1) and V40Gy of 52.7% (47.6 - 64.9%, p  1). Evaluated bladder
dose-volume parameters were comparable with near maximum doses D2% of 66.7Gy
(66.0 - 67.3Gy) for manual plans vs. 66.7Gy (63.3 - 67.2Gy, p  1) and V60Gy of
27.6% (14.3 - 57.3%) vs. 27.5% (12.9 - 48%, p  1). A boxplot summarizing the
evaluated DVH parameters is provided in figure 26. The resulting values for all
evaluated parameters for manual and PSO plans are reported in table 5.
In total, 9 out of 10 PSO plans for postoperative treatments were clinically mean-
ingful. In figure 27, PC03 is shown as example for successful PSO planning and is
compared to the accepted manual RT treatment plan. Three representative slices
showing coronal, sagittal and axial views of the dose-distribution are provided for
the manual (figure 27a) and the PSO plan (figure 27b). At a first glance, the dose
distributions do not differ strongly. Deviations are visible for the high-dose isolines
at the interface between rectum and PTV, especially in the axial and sagittal views,
which are more conformal in PSO plans, indicating better rectum sparing. As is
clearly visible in all three views, bladder sparing was inferior for the PSO plan, with
the high and intermediate isodoselines reaching further into the bladder. This is
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Figure 26: Boxplots showing the distribution of DVH parameters for the 10 cases (*p<0.05).
Reprinted from [70] with permission from Elsevier.
also clearly visible in the DVH provided in figure 27 c). With 66.2Gy the PSO plan
nearly satisfied the preset of a rectum D2% smaller than 66Gy, but the manual plan
did not adhere to this restriction (D2%  67.5 Gy). To reach this limit, the bladder
was exposed to a slightly higher dose, demonstrated by a D2% of 66.8Gy in manual
plan vs. 67.2Gy in the PSO plan and also in the volume parameter V60Gy where in
the manual plan only 23.5% of the bladder volume were exposed to 60,Gy, whereas
for PSO V60Gy it was 28.6%.
Figure 28 presents dose distributions for the manual and PSO plans of PC01. This
was the only case where the resulting PSO plan was not clinically meaningful be-
cause of the poor target dose coverage. Figure 28 c) provides a DVH comparison
clearly showing that the human planner decided to exceed the bladder V60Gy restric-
tion (V60Gy   50 %) to fulfill the PTV prescription (c.f. to arrow). The PSO is
restricted by the definition of the PQS, where exceeding of the pre-defined DVH
parameters is strictly penalized. Therefore the PSO is unable to mimic this decision
and hence the proposed plan is clinically not acceptable.
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a) manual b) PSO
c) DVH comparision
Figure 27: Case PC03 as representative example for the 9 successful cases: dose distribution
in three representative slices of manual plan (a), PSO plan (b) and DVH comparison (c). For
PC03, a better rectum high dose sparing could be reached while accepting slightly inferior
bladder sparing. Augmented from [70].
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a) manual b) PSO
c) DVH comparision
Figure 28: Dose distribution in three representative slices of manual a) and PSO b) plans
and DVH comparison c) of case PC01. This is the only case where PSO could not propose
a clinically acceptable plan. During manual planning, it was decided to violate the bladder
V60Gy   50 % restriction to ensure dose coverage of the PTV (c.f. arrow). As PSO strictly re-






Table 5: Evaluated DVH parameters, MU and segments per plan and total score for all 10 cases for manual and PSO plans. If one of the plans
adhered better to the pre-defined clinical goals, it is highlighted in bold. Reprinted from [70] with permission from Elsevier.
PC01 PC02 PC03 PC04 PC05 PC06
Man PSO Man PSO Man PSO Man PSO Man PSO Man PSO
PTV EUD [Gy] 64.8 62.5 65.2 65.3 65.1 65.3 65.6 65.5 65.9 65.5 65.8 64.9
PTV D98% [Gy] 62.1 59.5 62.3 62.7 62.2 62.7 63.2 63.1 63.6 62.8 63.2 62.2
PTV D2% [Gy] 67.9 68.1 68.0 68.0 67.9 67.8 67.9 67.9 67.8 67.9 67.7 68.0
Rectum D2% [Gy] 67.4 64.8 66.7 66.1 67.5 66.2 67.2 66.4 67.0 66.1 67.0 65.8
Rectum V40Gy [%] 45.9 48.7 44.2 52.8 54.3 52.7 46.9 58.7 49.5 53.0 63.5 60.3
Rectum V60Gy [%] 25.9 22.8 19.2 23.5 28.9 27.4 21.8 21.8 19.4 19.0 34.7 33.4
Bladder D2% [Gy] 66.0 63.3 66.7 66.4 66.8 67.2 66.5 66.5 66.8 66.6 67.3 66.2
Bladder V60Gy [%] 57.3 48.0 14.7 12.9 23.5 28.6 14.2 13.9 16.6 13.2 33.4 26.3
MU 585.3 553.7 507.4 606.3 606.8 536.3 486.1 485.1 421.2 500.4 434.8 579.1
Segments 185 186 183 207 190 194 182 182 164 193 166 195
Total PQS -16.43 -5.98 -0.99 1.23 -0.61 0.43 0.56 0.78 0.06 0.99 -1.95 1.07
PC07 PC08 PC09 PC10 manual PSO
Man PSO Man PSO Man PSO Man PSO Median Range Median Range
PTV EUD [Gy] 65.6 65.4 64.7 65.4 65.4 65.0 65.5 65.4 65.4 64.7 - 66.0 65.3 62.5 - 65.5
PTV D98% [Gy] 63.3 62.8 61.7 62.8 62.7 62.2 63.0 62.8 62.9 61.7 - 63.6 62.8 59.4 - 63.1
PTV D2% [Gy] 67.4 67.5 68.0 67.9 67.9 68.0 67.6 67.7 67.7 67.4 - 68.0 67.9 67.5 - 68.1
Rectum D2% [Gy] 66.9 66.2 67.3 65.9 66.6 66.5 66.5 64.7 67.0 66.5 - 67.5 66.1 64.7 - 66.5
Rectum V40Gy [%] 58.2 51.6 42.7 52.5 48.2 47.6 38.5 64.9 47.6 38.5 - 63.5 52.7 47.6 - 64.9
Rectum V60Gy [%] 23.6 22.0 21.4 22.0 30.5 30.0 12.1 13.0 22.7 12.0 - 34.7 22.4 13.0 - 33.4
Bladder D2% [Gy] 66.8 66.9 66.2 67.0 66.9 66.9 66.8 66.9 66.8 66.0 - 67.3 66.7 63.3 - 67.2
Bladder V60Gy [%] 31.7 38.0 41.4 45.6 19.0 18.2 35.7 38.6 27.6 14.3 - 57.3 27.5 12.9 - 48.0
MU 488.4 490.1 621.1 545.4 511.3 563.2 594.7 540.5 525.7 421.2 - 621.1 540.0 485.1 - 606.3
Segments 192 196 196 189 188 202 201 199 185 164 - 201 194 182 - 207
















































Figure 29: Comparison of the DVH spread for PTV a), rectum b) and bladder c) for cases
PC02 -PC10. The colored DVH band comprises all individual DVHs of patients with clinically
acceptable PSO plans (PC02 -PC10). The arrow in b) highlights the high dose region, where
manual and PSO plans are clearly separated. Augmented from [70].
Figure 29 presents DVH comparisons for all 9 clinically acceptable plans (PC02 -
PC10) for PTV, rectum and bladder. The clinically unacceptable plan for PC01
was excluded from this analysis. For a DVH analysis for this case, see the previous
paragraph and figure 28 c). For figure 29, for each dose bin minimum and maximum
volume fractions for all 9 individual DVHs were plotted. Therefore all individual
DVHs are included in the shaded areas. An indication for the lower inter-plan vari-
ation in PSO plans is the narrower band, especially in the PTV DVH in figure 29
a) and in the rectum high dose region in b). This is also encouraged by the lower
interquartile range for PTV parameters in the boxplot of figure 26. The DVH com-
parison also clearly shows the better rectum high-dose sparing in PSO plans, as
in the high dose region the bands for PSO and manual plans are clearly separated
(c.f. figure 29 b)). Patient individual bends in the PQS caused a broader range for
volume parameters, such as V40Gy and V60Gy. As the bladder filling extremely influ-
ences the possible dose sparing and hence reachable dose-volume constraints, this is
even more pronounced in the dispersion of bladder DVHs (c.f. figure 29 c)). These
points are also reflected in the boxplots in figure 26.
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Figure 30 summarizes individual and total PQS for all 10 cases, supporting the
presumption of comparable PTV EUDs for manual and PSO plans in most cases.
Rectum D2% always scored better in PSO plans than in manual plans, correspond-
ing to better rectum high dose sparing. Rectum V60Gy also scored better in PSO
plans, also indicating better rectum dose sparing in PSO plans. This is however
partially reached due to inferior rectum V40Gy in PSO plans. But V40Gy is within
the restriction defined by the SOP, whereas especially rectum near maximum dose
(D2%) was normally exceeded in manual plans.
For 8 out of 10 cases, the total PQS was higher in PSO plans than in to manual
plans, which was to be expected as the PSO uses the PQS directly as guidance for
the optimization. Conversely, a human planner in principle knows the same limits,
but does not receive direct feedback about the PQS during the trial-and-error plan-
ning process. The total PQS seems to be mainly driven by the rectum D2% PQS.
In cases where manual plans scored much worse than PSO plans, e.g. case PC01,
PC06 and PC08 in figure 30, the total PQS was also divergent. In contrast, for cases
where rectum high dose sparing was comparable, e.g. case PC09, the total PQS was
also comparable.
Figure 30: Overview of the individual scores for all 10 cases for manual and PSO plans.
PTV D2% is not presented as all cases fulfilled this parameter (PQS=0), bladder V60Gy is
not presented as all cases obtained PQS=1, except for PC01:-14.60 manual and 0.41 PSO.
Reprinted from [70] with permission from Elsevier.
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Modern RT treatment planning is an optimization problem, as the prescribed tumor
dose needs to be reached, while OARs have to be spared from dose burden as much
as possible. Inverse planning aims to achieve this by using constraints and objectives.
A constraint is a prerequisite that has to be fulfilled, whereas an objective should
be adhered to as much as possible. Depending on the patient’s anatomy, individ-
ual trade-offs between constraints and objectives have to be defined. Therefore the
formulation of the optimization problem is challenging, whereas the solution of the
problem is well known. To find a good plan for each individual patient, the treatment
planner has to try out different combinations of objectives and constraints. As this
is a time consuming trial-and-error process, automatic planning has gained attention
in recent years [1–7]. Although some of these approaches are already implemented in
clinical practice, planning automation is still an active field of research. The usage
of non-convex constraint functions and the increasing complexity of search spaces
are particularly demanding. Statistical optimization techniques such as genetic algo-
rithm (GA) and particle swarm optimization (PSO) entered into the field to address
this requirements [58–64].
In the presented work, an automatic planning approach based on PSO was proposed
and implemented. The plans were generated by using the TPS Hyperion, which uses
constrained optimization to generate pareto-optimal plans. Nevertheless, the plan-
ner needs to balance the constraints to turn a pareto-optimal plan into a clinically
acceptable plan by trying different combinations of planning constraints. This trial-
and-error process can be seen as a manual exploration of the pareto-surface, which
may however be ineffective and biased by the planner’s experience. An automatic
exploration of the pareto-surface was already introduced by Craft et al. [49, 50]. The
automatic PSO planning approach proposed in this thesis can be seen as an efficient
way to explore the pareto-surface, as it is able to automatically select an optimal,
clinically acceptable plan for individual patients. Throughout this discussion the
quality of the implementation is discussed (section 4.1), followed by a comparison to
other automatic planning approaches in section 4.2. The section concludes with com-
ments on the proof-of-principle study on n=10 post-operative prostate treatments.
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4.1 Implementation of PSO for RT planning
Overall, the analysis of the PSO implementation for RT planning showed that the
PSO is able to converge to a clinically meaningful position in the search space and
that this position is a global optimum. A good balance between exploration in the
beginning and exploitation of the global optimum throughout the PSO was also
shown. Nevertheless, there is potential for future improvements, for example with
regard to the implementation of the PSO as well as the PQS.
In section 3.2, it was mentioned that particles can be trapped at the boundary, be-
cause of how particles hitting the boundary are treated in the software. A particle
that hits the boundary has a relocation vector pointing outside the search space. In
the beginning, when the inertia weight is still high, it can take some generations
until the attraction to the local and global optimum, pulling the particle back into
the search space, can outweigh the inertia component. Hence, the particle will be
trapped at the boundary for several generations. As the optimum PSO plan is not
expected to lie on the boundary, this over-exploration of the boundary is unnec-
essary. To avoid this, the procedure for particles hitting the boundary should be
changed. A potential solution to this may be to reflect the particle back into the
search space. But this will cause a relocation vector which is not related to any
attraction point, i.e. neither to the local nor global best position. Yet a simpler
approach would be to stop the particle at the boundary, i.e. setting the relocation
vector to 0Gy. Then the local and global best positions will act as attraction points
and will bring the particle back into the search space. While the inertia component
would be irrelevant in this approach, it nonetheless seems rational given that the
particle was facing outside the search space, i.e. into a clinically irrelevant region.
The 3D-plots of all positions visited in the search space (figure 21 and 22) clearly
demonstrate that the exploration ability of the implemented PSO is good. The
exploitation ability around the final best positions also seems to be sufficient. Nev-
ertheless, in the plots of the positions defined by constraints there seem to be local
optima, i.e. well scored positions close to the final best position, which are not fur-
ther exploited. It could be shown, that this observation is a misinterpretation of
particle position. Due to a feature of the TPS Hyperion for plans defined with non-
binding constraints, the achieved dose-effect will be lowered thoroughly. Therefore
a position definition by achieved dose-effects was additionally plotted in figures 21
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and 22. With this improved position definition, it is evident that the PSO was able
to find the global optimum. This difference in position definitions may however mis-
lead the PSO, as it introduces a discrepancy between supposed position of a plan on
the pareto-surface and the actual true position of the plan. As the actual position
of a particle xi,d, the particle’s best achieved plan (pbest,i) and also the swarm’s best
position (gbest) are used to calculate the relocation for the subsequent generation
this discrepancy could affect the position update. The improved position definition
might be considered in a future implementation. By implementation of this updated
position definition using dose-effects Gj instead of constraints Cj, the problem of
particles sticking to the boundary can potentially also be solved, as these particles
were all affected by tightening of non-binding constraints. This is shown in figures
21 and 22 d) to f), where no particles hit the boundary. But still this may only
be sufficient with a reset of the inertia component of the relocation vector, because
otherwise inertia would still point outside the search space. And as shown in the
beginning of PSO where inertia is the driving force for relocation, this may cause
the particle to be thrown back to the search space boundary. It should also be eval-
uated if the discrepancy between position definitions can mislead the optimization
to a final best position with non-binding constraints. This should be done in con-
junction with the definition of the PQS, because in general plans with non-binding
constraints may contradict defined dose sparing for OARs, and therefore should be
scored lower. Nevertheless, the plots with positions defined by constraints show that
combinations with non-binding constraints also scored well, although they did not
reach the best score.
Currently the search space is large, especially in the direction towards the lower
boundary. However, it was shown that this huge search space is only explored dur-
ing the first PSO generations and that in later generations, the optimization focused
on the more promising region around the final best position. In terms of efficiency
and convergence speed, it may be possible to shrink the search space from the begin-
ning. But it is visible from the two rectum constraints that this shrinking need to be
in close connection to the meaning of the constraints, as a constraint which controls
the low or intermediate dose region in an OAR will take lower values than a high-
dose constraint and may also show more intra-patient variation. It was also shown,
that constraints are interacting with each other. Especially if two constraints control
different regions of the DVH for the same OAR. Therefore it could be promising
to restrict the search space to meaningful combinations of such constraints. In the
example of two rectum constraints, where one restricts the high dose and one the in-
termediate dose region, it seems to be obvious that the intermediate dose constraint
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should be set to a lower EUD level than the high dose constraint.
As described in section 3.1, the ability of the constraints to converge and the ability
to meet the set convergence criterion of  0.1 % difference in mean constraint in
subsequent generations and an interval of less than 1Gy between maximum and
minimum constraint differs over the three constraints. It is noticeable that the
rectum constraint C1 converged in all cases whereas the interval criterion for the
second rectum constraint C2 was never met and for the bladder constraint C3 only
in 4 out of 10 cases. Nevertheless, it is notable that for some cases the termination
criterion was nearly met. From the analysis it is not clear why this difference occurs.
However, as the convergence was fully reached for one constraint, it is evident that
this is not due to the implementation of the PSO. Instead, this probably arises from
the definition of the PQS, which is critical for the success of the optimization. It
should be further investigated if all constraints are depicted and balanced properly
by the PQS.
The implementation used the Python random module, which is by default initialized
by date and time of the server. The module gets reinitialized every time a Python
script is called. As the implementation is constructed of several Python scripts (see
section 2.1.2) which are controlled and iteratively executed by a bash script, the ran-
dom module gets reinitialized several times. For an improved PSO implementation,
the status of the random module should be tracked and then set with every recall
of the Python script to fully utilize the random module.
Computation time is a key potential benefit off automatic planning approaches:
preferably they should be faster than manual planners. Depending on the complex-
ity of the intended treatment, an optimization time of 30min for a simple prostate
and up to several hours for complex head and neck VMAT treatments are realistic.
Nevertheless the implemented automatic PSO planning is currently much slower.
Currently, it takes around 3-5 min per plan to compute a plan on our server with
18 Intel® Xeon® Processors X5650. Thus, for a swarm of 30 particles executing 100
generations, the total computation time for 3000 plans is about 140 - 250 h, which at
the moment impedes clinical application. As the implementation was not optimized
for computation time for this study, time gain is probable with an enhanced imple-
mentation. As could be seen in the flowchart provided in figure 13, the computation
of the individual plans per generation and the scoring are mutually independent.
Therefore a straightforward way to speed up the PSO would be the parallelization
of the plan computation within each generation. Computation on a graphics pro-
cessing unit (GPU) is also not yet implemented for the TPS Hyperion and would
boost the computation time per plan.
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For the specific implementation, the choice of the inertia weight ω is crucial for the
convergence ability and consequently influences the computation time for the entire
PSO [74, 75]. As the inertia weight ω is intended to balance the exploration and
exploitation ability of the swarm, a reduction seems to be reasonable. Currently,
the inertia weight is reduced from 1.4 to 0.2 by 0.2 every 10th generation. A sub-
ject of further research should be the influence of different reduction schemes, such
as linear functions of different steepness or other regimes promoting exploration or
exploitation.
In the presented proof of principle study, post-operative prostate cancer cases were
only planned using serial constraints. As serial constraints belong to the group
of convex planning constraints, the search space was not expected to have local
optima or discontinuities. This was verified by the plots in figures 21 and 22. Nev-
ertheless, the full potential of a statistical optimization like PSO might only be
visible for treatment planning problems with non-convex planning constraints. For
a PSO implementation with non-convex constraints the search space might change
tremendously and hence the number of particles I, the number of generations D and
the inertia weight ω should be carefully chosen to ensure a good balance between
exploration and exploitation and also to reach convergence to a global optimum.
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4.2 Automatic PSO in comparison to other
automatic planning approaches
In the past, different approaches to navigate the pareto-surface were explored. A
first approach was introduced in 2006 by Craft et al. [49, 50]. They showed that
by relying on a few pre-calculated pareto-optimal plans, the pareto-surface can be
approximated by linear-combinations of these anchor points. The task of the man-
ual planner is then to try out different linear-combinations. The planner thereby
explores the pareto-surface manually. Afterwards, he or she has to decide which
plan should be used for treatment. The calculation of the linear-combinations is
fast and hence the planner can navigate the pareto-surface interactively. Another
approach to calculate pareto-surfaces was recently introduced by van der Bijl et
al. [54]. In this approach, the automatic planning approach iCycle [27] is used to
compute 40 plans for cases in the training cohort. Afterwards, a super ellipsoid is
used to fit the patient individual pareto-surface to this pre-calculated plans. By
extracting anatomical features, a prediction model is developed, which has been suc-
cessfully used to predict the pareto-surfaces for the cases in the validation cohort.
The pareto-surface can then be evaluated by a human planner to explore planning
trade-offs. The main difference between these two approaches and the presented
automatic PSO planning in this thesis is that in the latter, the pareto-surface is
explored automatically and quasi-continuously. The PSO approach therefor is far
more expensive in terms of computational cost, which at the moment is around
150-200 h. Moreover, in the PSO approach the decision regarding the clinical plan
is made by applying well-defined quality measures (PQS) and not by the subjective
choice of a human planner. Another conceptual difference to the approach proposed
by Craft et al [49, 50] is that the usage of linear-combinations of anchor points is
inherently restricted to convex search spaces. The fit of an super ellipsoid in the
approach of van der Bijl [54] is also restricted to a convex search space. In contrast,
the statistical nature of the PSO is in principle capable of non-convex search spaces
with local optima.
The Pinnacle AutoPlanning Module is already widely used in clinical routine plan-
ning for different treatment sites [19–25]. The approach uses voxel-based importance
factors for sub-optimal regions of ROIs or DVH regions. These sub-optimal regions
are automatically identified by comparing the actual case to a similar case in a
database of previously treated patients. The quality of Pinnacle AutoPlanning is
thus restricted by the quality of the plans in the database. The same inherent lim-
itation applies all other automatic planning approaches which rely on a database
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of previously treated patients, such as RapidPlan implemented for the TPS Eclipse.
RapidPlan uses a model built from previously treated plans to predict feasible DVH
constraints from the known patient individual anatomy [38].
Machine learning and deep learning also recently entered the field of automatic
planning. With machine learning it is possible to predict single DVH points for
individual patient anatomies, again on the basis of a model built form previously
treated patients. As a DVH is not sufficient to judge plan quality and the 3D-dose
distribution is equally important, deep learning is used to learn dose distributions
for individual patients. Deep learning approaches showed promising solutions for the
prediction of high dose regions around the PTV, but prediction of low dose regions
and hence reliable prediction of OAR sparing is challenging [56, 57]. As plan quality
is not only affected by the patients anatomy, but also by treatment accessories such
as used machines or gantry angles, the solely usage of 3D-distributions may be insuf-
ficient. Deep learning may also identify dose distributions which are not applicable
as at the moment only the final dose distribution is used as input for learning the
model, whereas restrictions entered by the used LINAC are neglected.
A template based automatic planing approach is Erasmus iCycle, which uses pre-
defined wishlists of hard and soft constraints [26, 27]. The whislist has a categorical
order and defines the planning goals in descending priority. As the order and type
of planning constraints are fixed, only the constraint value is altered patient specifi-
cally to meet as much of the planning goals as defined in the whislist. As described
in section 1.4 the implemented 2-phase ε-constraint (2pεc) optimization method has
the hazard to be trapped at inferior objective combinations, where a small gain in
a high prioritized OAR prevents a large dose sparing for a lower prioritized struc-
ture. This limitation is true for optimization techniques which rely on derivative
information, but may be overcome by statistical optimization such as GA and the
proposed PSO approach. In Erasmus iCycle this problem was solved by introduc-
ing the LRPM [36, 37] (for details see also 1.4). The LRPM uses tilted indifferent
curves in the optimization space to define global trade-offs between conflicting objec-
tives. In this manner, the method overcomes the trapping problem. However, it still
uses derivative information and is therefore not applicable for non-convex objectives.
Again, due to the statistical nature of the PSO, the optimization would in principle
be capable to take non-convex functions into account, although this has not yet
been demonstrated in practice. For the proof-of-principle study with post-operative
prostate cases, only convex constraint functions were used.
Optimization with genetic algorithms (GA) belongs to the statistical nature-analo-
gous optimization techniques, such as PSO. The approach implemented by Fiandra
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et al. for automatic planning of prostate VMAT treatments using GA [58, 59] is
conceptually similar to the presented automatic PSO planning. The GA optimizes
the combination of rectum and bladder serial maximum constraints by adopting
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CI and PD are conformity index and prescribed dose, whereas rAD, bAD, lfAD
and rfAD are average doses of rectum, bladder and left and right femoral heads.
Therefore, the fitness function is much simpler than the PQS used as fitness function
for the PSO implemented in this study. But it should be mentioned that Fiandra et
al. used a fitness function to score the option plans which evaluate PTV coverage and
mean OAR doses, whereas in the optimization serial maximum constraints are used
for rectum and bladder. Therefore, the fitness function evaluates a plan parameter
which is only indirectly controlled during the plan optimization. Also the coverage
of the target and mean OAR doses are not the sole criterion used to judge plan qual-
ity in clinical practice (see [59]). In contrast, the PQS used to evaluate plan quality
in the PSO implementation is designed in a way to score all plan parameters which
are evaluated clinically. This was done by adopting the institutional SOP in the
PQS. Furthermore all the parameters included into the PQS were controlled by the
optimization. For example the PSO optimized two rectum constraints. One for the
high dose region, which is reflected by the individual PQS for near maximum dose
D2% and V60Gy. Whereas the second rectum constraint was to control mid dose con-
straint, which was reflected by the individual PQS for V40Gy. An interesting point in
the fitness function proposed by Fiandra et al. is the normalization of the OAR mean
doses to the prescribed tumor dose [58]. This makes the fitness function suitable for
different prostate treatments with varying prescribed tumor doses. In contrast, the
PQS in our PSO implementation is specifically designed for post-operative prostate
treatments and the transferability to other prostate treatments is the subject of on-
going research. Another fundamental difference between GA and PSO is that GA
is a statistical optimization which explores the search space at random: there is
no interaction or sharing of knowledge about positions in the search space already
visited. In contrast in PSO the sharing of knowledge is an inherent feature and the
information regarding individual particles’ best positions and swarm’s global best
position are directly taken into account to calculate position updates.
Some approaches for using PSO in the field of treatment planning have already been
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proposed. The approach proposed by Yang et al. is similar to ours, as they used
the PSO to set weighting factors in IMRT optimization [69]. Weighting factors and
constraints are interchangeable objects in a multi-objective optimization. It is pos-
sible to define an optimization problem by setting the one ore the other and then
the absent one is part of the solution. The principle idea is similar to the presented
approach, a particle is considered a plan and the plan’s position is then determined
as a set of weighting factors or constraints. The position updates are computed by
incorporating the information about particles’ best and swarm’s best positions in
both approaches. Both approaches also use key points of the DVH as the basis of
the evaluation function, called PQS in the presented approach. Nevertheless, the
present approach uses one pre-defined PQS for the entire course of PSO, where the
PTV coverage and the OAR sparing are considered concurrently. In contrast Yang
et al. [69] use three different evaluation functions over the course of PSO: the first
one should ensure PTV coverage. Once a satisfying plan is reached, the evaluation
function is changed to evaluate high dose sparing for OARs and tries to minimize
that dose burden, but at the same time the PTV coverage needs to be kept. The
third evaluation function then evaluates the low dose sparing. They tested the im-
plementation with 10 prostate cases, which were planned successfully. Comparison
of DVHs showed that the manual planning and PSO planning reached similar so-
lutions, if the same objective functions were used. Yang et al. enhanced the PSO
implementation by integrating crossover and mutation strategies, known from GAs,
mainly to avoid trapping at local optima [69]. Both PSO implementations showed
that PSO is useful for automatic planning, nevertheless the crucial point is the
evaluation of the candidate plans. Both implementations also presented successful
evaluation strategies for simple prostate cases. However, the generalization for more
complex planning tasks should be the focus of further research.
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4.3 Proof of principle - PSO implementation for
post-operative prostate RT
The automatic PSO planning was successfully implemented and tested for 10 post-
operative prostate cancer cases. Manual planning relies on a trial-and-error process
and therefore mainly on the planner’s experience and time. In contrast, in auto-
matic PSO planning even unlikely constraint combinations are explored by chance
and the process is reproducible. In 9 out of 10 cases, PSO proposed a clinically
acceptable plan. One case (PC01), where the proposed PSO plan offered insufficient
PTV coverage, failed due to an unfavorable patient anatomy. The manual planner
decided to exceed restriction of dose burden to the bladder to ensure the PTV dose.
In difference to the manual planner, the PQS which guides the PSO is defined for a
common clinical situation and reflects the criteria of the institutional SOP. There-
fore, the PSO strictly adhered to the requested bladder V60Gy specification and the
PSO plan compromised the PTV dose to an unacceptable level of EUD=62.5 Gy.
Sacrificing OAR restrictions to ensure PTV dose coverage is in the responsibility
of the clinician and should be decided carefully and individually for each patient
depending on the clinical situation. After discussion with the clinician, the planner
can then alter planning constraints accordingly. Nevertheless, as this is a patient
individual decision, it cannot be reflected in the definition of a common PQS.
For Pinnacle AutoPlanning and Erasmus iCycle gains for PTVs and OARs over all
DVH regions were reported [1, 22, 24, 32]. In contrast, for the tested post-operative
prostate cases planned with the automatic PSO approach only an superior rectum
high-dose sparing was reported, compared to the manual plans. This reflects the con-
ceptual difference of the strategy. The automatic PSO planning was implemented
in conjunction with the TPS Hyperion, which provides pareto-optimal plans for all
planning problems. To turn a pareto-optimal plan into a clinically favorable plan,
competing constraints have to be well balanced and the used constraints need to
reflect and probably control the clinical interests. For this study, the constraint
types were not changed between manual plans and automatic PSO plans, moreover
all plans were generated with TPS Hyperion and are hence considered as pareto-
optimal. Therefore a gain for all DVH regions of PTV and OARs in the automatic
PSO plan is not to be expected, as this would contradict the pareto-optimality of
the manual plan. For the presented approach the superior rectum high-dose spar-
ing comes at the cost of a slightly inferior bladder sparing, but this still adheres to
the planning goals defined in the institutional SOP. The rectum dose sparing at
the cost of bladder sparing is inherently due to the definition of the PQS, where
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more dose-points are allocated to the rectum than to the bladder. This reflects the
institutional standard, where rectum dose sparing is considered slightly more impor-
tant than bladder dose sparing. Other compromises may also have been possible,
depending on the implementation of PQS. Yang et al. implemented a similar PSO
approach, yet using a different paradigm for the evaluation function. Nevertheless
they also showed that if for manual and PSO plans the same constraint types are
used, the resulting differences will be small [69]. This supports the assumption that
large gains in dose sparing for OARs and PTVs are only reached due to different
optimization or changed objective and constraint functions in manual and automatic
planning.
For the presented automatic PSO planning approach, it is crucial to have a tool
which independently measures the quality of treatment plans, which is needed for
an objective comparison of inter- and intra-patient differences. During the manual
planning process, planners are normally empirically affected by their experience and
they do not have a clearly defined quality measure in mind. Furthermore there is
no prompt feedback about plan quality during the trial-and-error process. In con-
trast, the automatic PSO planning uses the PQS for evaluation and is guided by
this throughout the course of optimization. Hence, the definition of the PQS is
crucial and needs to be done very carefully. The PQS is defined as treatment in-
tent and treatment site specific class solution, which is referred to as a well-defined
standard and should therefore reduce inter-patient variation. This was also shown
for the PTV coverage of the presented post-operative prostate cases. Nevertheless,
PQS is also able to account for individual patient anatomy, i.e. if a superior OAR
sparing is possible without deteriorating PTV dose this compromise would be pre-
ferred, due to the increased PQS. The PQS was also customized for the planning
goals which are highly related to patient anatomy, such as the volume parameters
V40Gy and V60Gy for rectum and bladder. A further refinement of the PQS could be
the prioritization of OAR structures: this might be even more important for more
complex treatments where more different OARs will contribute to the total PQS.
At the moment, all individual PQS for the different dose-points of different struc-
tures are set to the same maximum value, but in principle it would be possible to
set different maximum contributions to the total PQS and thereby prioritize some
planning goals over others. Nevertheless, this would not be a strict prioritization as
in principle a less prioritized OAR can still outweigh a higher prioritized one, if a
significantly better dose-sparing is reached, as PQS increases in this situation. For
the presented post-operative prostate cases the PQS is relatively simple, neverthe-
less it is treatment site and intent specific. Even a PQS for other, more complex
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prostate treatments probably needs to integrate additional OARs such as urethra,
penile bulb or femoral heads. Currently, the PQS is solely based on DVH param-
eters, as these are clinically well-known measures of plan quality. But in principle,
it should be possible to integrate further characteristics such as machine parame-
ters or complex tumor control probability (TCP) and normal tissue complication
probability (NTCP) models in a future implementation.
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In this work, PSO was for the first time used as automatic treatment planning for
RT VMAT treatments. The PSO was successfully implemented and integrated into
the TPS Hyperion and used as an automatic VMAT treatment planning approach.
The PSO implementation was analyzed concerning the balance of exploration and
exploitation and the convergence ability. As intended, the implemented reduction
scheme for the inertia weight ω steered the exploration in the beginning and pro-
moted exploitation over the course of PSO. Nevertheless, other reduction schemes
for the inertia weight may be worth investigation in the future. The stabilization
of the mean constraint value over all particles in subsequent generations in com-
bination with the distance between maximum and minimum constraint value was
analyzed and identified as a potential convergence criterion for a future implemen-
tation. Concerning this criterion, the principle convergence ability of the PSO was
proven. Nevertheless, the three used planning constraints converge in a different
time frame and the convergence ability also differs between the cases. Therefore, in
a future implementation such a convergence criterion could be used as the termi-
nation criterion for the PSO as it would save time for cases converging before the
maximum number of generations is reached, whereas for other cases some more itera-
tions of the PSO could have yielded a superior solution. Currently, the optimization
time of several days would impede clinical application, but the implementation was
not yet optimized for computation time. One straight-forward way would be to
calculate all plans within one generation at the same time, i.e. a parallelization of
the PSO.
With the implemented automatic PSO planning approach, 10 post-operative prostate
cases were automatically planned and showed similar plan quality compared to man-
ually optimized VMAT plans. The PQS was introduced as a measure of plan quality,
which is based on well-defined DVH parameters which are widely used in clinical
practice to judge plan quality. For 9 out of these 10 post-operative cases overall
comparable PTV dosage was reached, whereas rectum is significantly better spared
from high doses. This improved rectum sparing was reached by accepting inferior
bladder dose sparing, but bladder dose parameters still fulfilled clinical requirements.
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This different compromise between rectum and bladder dose is directly reflected by
the PQS. In principle other compromises are possible, depending on the definition
of the PQS. The PQS should be further refined and should integrate more complex
plan quality measures such as normal tissue complication probability (NTCP) and
tumor control probability (TCP) models.
Automatic treatment planning using PSO is technically feasible and highly promis-
ing for future clinical applications. Nevertheless, the implementation of the PSO
and the definition should be further refined to use PSO for clinical RT treatment
planning. The transferability to other treatment sites also needs further investiga-
tion. Additionally, further planning studies and comparative trials are needed to
prove the clinical applicability of this approach.
76
6 Summary
All RT treatments need to be planned patient individually to ensure the best plan
for each patient. For modern VMAT treatments inverse planning, where planning
objectives and constraints are used to describe the dose prescribed to the target and
the accepted dose burden to the surrounding healthy tissues, is state of the art. But
depending on the patient anatomy, the dose burden that needs to be accepted to
ensure target coverage with sufficient radiation dose may differ. Therefore, in man-
ual planning different combinations of constraints and objectives need to be tested,
which turns planning into a trial-and-error process which is highly related to the plan-
ner’s experience and also to the available time. In this context automatic, planning
gained attention in recent years and already showed its applicability and advantages
in clinical practice [1–7]. Nevertheless, automatic approaches introduced thus far
normally incorporate differential information to guide an optimization, which is only
successful with convex constraint functions. Statistical optimization techniques are
promising to overcome this problem, because they explore the search space ran-
domly.
PSO is such a nature-analogous, statistical, iterative and collective optimization
technique, which is inspired by the behavior of a swarm of fish or bird. A swarm
is formed by particles, which explore a search space randomly. By sharing infor-
mation regarding the quality of positions visited so far in the search space, each
particle iteratively alters its position to approach the global optimum. In this work,
an automatic planning approach based on PSO was implemented and successfully
tested for post-operative prostate cases. For RT treatment planning, each particle
equals a plan, with the position in the search space defined as a vector of planning
constraints. PSO is used to manipulate these planning constraints iteratively and
was implemented in this doctoral thesis in Python 2.7.3. Attached to the TPS Hy-
perion for plan generation, an automatic treatment planning approach was realized,
analyzed and tested.
In the first part of this work, the implementation was tested by analyzing the explo-
ration and exploitation ability. As intended by the inertia weight ω, the exploration
dominates in the beginning and during the course of PSO exploitation is promoted.
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Moreover, the convergence ability of the PSO was analyzed by monitoring the sta-
bilization of the mean constraint values over all particles in subsequent generations
and the distance between maximum and minimum constraint values. Overall, the
implementation of the PSO is suitable for the usage as an RT planning approach.
Nevertheless, the implementation should be further refined, especially to promote
computation time.
The crucial point for all automatic planning approaches is the fair and reproducible
comparison of competing plans. Especially for optimization algorithms, it is impor-
tant to define what an optimal plan looks like, because this information is used by
the algorithms to determine the further search direction. In this study, a plan qual-
ity score (PQS) based on well-known DVH parameters was introduced to measure
plan quality. The DVH parameters were adapted from the institutional SOP and
thereby our PQS reflects the clinical standard. In principle, the PQS rewards the
adherence of the DVH criterion and penalizes its violation.
A PQS dedicated to post-operative prostate cases was implemented for this study.
Using this PQS, 10 post-operative prostate cases were planned automatically with
the implemented PSO and compared to manual plans in the second part of this
work. Compared to manual plans, the automatic PSO plans were comparable in
over-all plan quality. Nevertheless, PSO plans reached significantly better rectum
high dose sparing, while accepting slightly inferior bladder dose sparing. This differ-
ent compromise reflects the definition of the PQS. Other compromises would also
have been possible.
In this work, the applicability of PSO as an automatic planning approach was proven.
Nevertheless, as the PQS is defined treatment site and intent specific, the transfer-




Strahlentherapeutische Behandlungen werden für jeden Patienten individuell ge-
plant, um den bestmöglichen Plan zu gewährleisten. Moderne VMAT-Behandlungen
werden heute standardmäßig invers geplant, dabei werden Planungszielvorgaben und
-beschränkungen genutzt, um die Dosis im Zielvolumen und im umliegenden gesun-
den Gewebe zu charakterisieren. Je nach individueller Patientenanatomie muss un-
terschiedlich viel Dosis im gesunden Gewebe akzeptiert werden, um die Abdeckung
des Tumors mit der benötigten Dosis zu gewährleisten. In der manuellen Planung
müssen dafür unterschiedliche Kombinationen von Zielvorgaben und Beschränkun-
gen erprobt werden. Damit hängt der Planungsprozess maßgeblich von der Er-
fahrung des Planers und der zur Verfügung stehenden Zeit ab. In den letzten Jahren
wurden daher verschiedene automatische Planungsansätze vorgeschlagen, für die An-
wendbarkeit und Nutzen bereits gezeigt wurden [1–7]. Alle bisher vorgeschlagenen
Ansätze nutzen differentielle Informationen als Grundlage für die Optimierung, was
ihre Anwendung auf einen Suchraum, der durch konvexe Beschränkungen beschrieben
wird, begrenzt. Statistische Optimierungen stellen eine vielversprechende Möglichkeit
dar, dieses Problem zu beheben, da sie den Suchraum zufällig erkunden.
Die Partikelschwarmoptimierung (PSO) ist ein solches naturanaloges, statistisches,
iteratives und kollektives Optimierungsverfahren, welches sich am Verhalten von
Vogelschwärmen oder Fischgruppen orientiert. Ein Schwarm setzt sich dabei aus In-
dividuen, auch Partikel genannt, zusammen, welche den Suchraum zufällig erkunden.
Indem die Partikel Informationen über die Güte der von ihnen besuchten Positio-
nen austauschen, verändert jeder Partikel seine Position im Suchraum iterativ und
versucht dabei, sich dem globalen Optimum anzunähern. In dieser Arbeit wurde
ein automatischer Planungsansatz beruhend auf einer PSO implementiert und erfol-
greich für post-operative Prostatakrebsfälle getestet. Für die strahlentherapeutische
Planung entspricht dabei jeder Partikel einem Plan, dessen Position im Suchraum
durch einen Vektor von Planungsbeschränkungen definiert wird. Die PSO verändert
die Beschränkungen iterative. Dies wurde in dieser Doktorarbeit in Python 2.7.3
realisiert. In Verbindung mit dem Bestrahlungsplanungssystem Hyperion, das zur




Im ersten Teil der Arbeit wurde die Implementierung analysiert, dafür wurde die
Fähigkeit des Algorithmus untersucht, den gesamten Suchraum zu erforschen und
einen kleineren Suchraum genauer zu erkunden. Dies wurde durch die Wahl des
Trägheitsgewicht ω umgesetzt. Weiterhin wurde das Konvergenzverhalten unter-
sucht, wofür der mittlere Wert der drei Planungsbeschränkungen zwischen aufeinan-
derfolgenden Generation und der Abstand zwischen höchster und niedrigster Be-
schränkung untersucht wurden. Dabei zeigte sich, dass die Implementierung geeignet
ist, um als automatischer Bestrahlungsplanungsansatz verwendet zu werden. Den-
noch sollte die Implementierung in Zukunft weiter verbessert werden, vor allem in
Hinblick auf die Rechenzeit.
Ein wichtiger Punkt für alle automatischen Planungsansätze ist der faire und re-
produzierbare Vergleich von zwei konkurrierenden Plänen. Vor allem für Opti-
mierungsalgorithmen ist es wichtig, einen optimalen Plan zu definieren, da diese
Information genutzt wird, um die weitere Suchrichtung festzulegen. In dieser Ar-
beit wurde ein ‚plan quality score‘ (PQS) eingeführt, der auf bereits bekannten
Dosis-Volumen-Histogramm (DVH)-Parametern beruht. Dafür wurden die DVH-
Parameter, die in der hausinternen ‚standard operating procedure‘ (SOP) definiert
sind, verwendet. Der PQS spiegelt damit den klinischen Standard wieder. Das
Prinzip des PQS beruht darauf, die Einhaltung der DVH-Parameter zu belohnen
und deren Verletzung zu bestrafen.
In der Studie wurde ein PQS für post-operative Prostatabestrahlungen implemen-
tiert. Dafür wurden 10 Fälle automatisch mit der implementierten PSO geplant
und im zweiten Teil der Arbeit mit den manuell erstellten Plänen verglichen. Die
manuellen und automatischen PSO-Pläne waren hinsichtlich ihrer allgemeinen Plan-
qualität vergleichbar, aber die PSO-Pläne erreichten eine signifikant bessere Scho-
nung des Rektums im Bereich hoher Dosen. Dafür musste eine etwas schlechtere
Schonung der Blase akzeptiert werden. Dieser unterschiedliche Kompromiss zwis-
chen Rektum- und Blasenschonung spiegelt die Definition des PQS wieder, es wären
aber auch andere Kompromisse möglich.
Damit wurde in dieser Arbeit die Anwendbarkeit der PSO als automatischer Pla-
nungsansatz gezeigt. Da der PQS spezifisch für jede Tumorentität und das Behand-
lungskonzept definiert werden muss, muss die Übertragbarkeit auf weiter Prostatabe-
strahlungen und andere Tumorlokalisationen in zukünftigen Studien untersucht wer-
den.
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A bash script called ’steuerung.sh’ monitored the PSO and the interaction with the
TPS Hyperion.
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A.2 initialize.py
19.05.21 initiliaze.py 1
file:///home/luise/IMRT_Research/Luise/autoplanning_data/PSO_scoring4/script/fuer_diss_druck/initiliaze.py
#!/usr/bin/env	python
#	coding:	utf8
import	os,	sys,	fileinput,	os.path
from	random	import	*
#initiliaze	particles
path	=	str(sys.argv[1])
patient_name	=	str(sys.argv[2])
part_nr	=	int(sys.argv[3])
nr_const	=	int(sys.argv[4])
l_limit	=	[53.63,40.85,48.95]							#patient	individual
u_limit	=	[63.63,50.85,58.95]
const	=	[0.0,0.0,0.0]
velos	=	[0.0,0.0,0.0]
particle_path	=	'%s%s_%i.txt'	%(path,patient_name,part_nr)
with	open(particle_path,	'a')	as	particle:
				particle.write('\n')
				i=0
				while	i	<	nr_const:
								x	=	randint(int((l_limit[i])*100),int((u_limit[i])*100))
								#print(x)
								x	=	x/100.0
								v	=	random()
								p	=	random()
								if	p	<	0.5:
												v	=	v	*	-1.0
								particle.write('%.2f,%.2f,'	%(x,v))
								const[i]	=	x
								velos[i]	=	v
								i+=1
				
CLN	=	os.path.join(path,	'%s_%i/'	%(patient_name,part_nr),	'%s.CLN'	%patient_name)
with	open(CLN,		'r')	as	f:
								lineList	=	f.readlines()
								j=0
								while	j	<	len(lineList):
												if	'isoconstraint'	and	'var1'	in	lineList[j]:
																lineList[j]	=	lineList[j].replace('isoconstraint=var1',	'isoconstraint=%.2f'	%const[0])
												elif	'isoconstraint'	and	'var2'	in	lineList[j]:
																lineList[j]	=	lineList[j].replace('isoconstraint=var2',	'isoconstraint=%.2f'	%const[1])
												elif	'isoconstraint'	and	'var3'	in	lineList[j]:
																lineList[j]	=	lineList[j].replace('isoconstraint=var3',	'isoconstraint=%.2f'	%const[2])
												j+=1
				
with	open(CLN,	'w')	as	f:
				j=0
				while	j	<	len(lineList):
								f.write('%s'	%lineList[j])
								j+=1
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A.5 get_gbest.py
19.05.21 get_gbest.py 1
file:///home/luise/IMRT_Research/Luise/autoplanning_data/PSO_scoring4/script/fuer_diss_druck/get_gbest.py
#!/usr/bin/env	python
#	coding:	utf8
import	os,	sys,	fileinput,	os.path
def	partition():
				return	head,sep,tail
patient_name	=	str(sys.argv[1])
path	=	str(sys.argv[2])
n_part	=	int(sys.argv[3])
nr_const	=	int(sys.argv[4])
b_fitness	=	[]
pbest	=	[]
i=0
while	i	<	n_part:
				with	open('%s/%s_%i.txt'	%(path,patient_name,i),	'r')	as	f:
								lineList	=	f.readlines()
								lastLine	=	lineList[len(lineList)-1]
								head,sep,tail	=	lastLine.partition(',')					#p1
								head,sep,tail	=	tail.partition(',')									#v1
								j=0
								while	j	<	(nr_const-1):
												head,sep,tail	=	tail.partition(',')									#p2
												head,sep,tail	=	tail.partition(',')									#v2
												j+=1
								head,sep,tail	=	tail.partition(',')									#fitness
								head,sep,tail	=	tail.partition(',')									#b_fitness
								#print(tail)
								b_fitness.append(float(head))
								j=0
								while	j	<	nr_const:
												head,sep,tail	=	tail.partition(',')									#pbest1
												pbest.append(head)
												j+=1
				i+=1
best	=	b_fitness.index(max(b_fitness))
with	open('%sg_best.txt'	%path,	'w')	as	f:
				f.write('%.4f,'	%(b_fitness[best]))
				i=(best*nr_const)
				while	i	<	((best*nr_const)+nr_const):
								f.write('%s,'	%pbest[i])
								i+=1
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